Activation	O
of	O
the	O
NF-kappaB	B-protein
transcription	B-protein
factor	I-protein
in	O
a	O
T-lymphocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
by	O
hypochlorous	O
acid	O
.	O

Reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
such	O
as	O
hydrogen	O
peroxide	O
serve	O
as	O
second	O
messengers	O
in	O
the	O
induction	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
,	O
and	O
hence	O
in	O
the	O
activation	O
and	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
in	O
human	B-cell_type
cells	I-cell_type
.	O

During	O
inflammatory	O
reactions	O
,	O
many	O
oxidative	O
species	O
are	O
produced	O
,	O
one	O
of	O
which	O
is	O
hypochlorous	O
acid	O
(	O
HOCl	O
)	O
,	O
which	O
is	O
responsible	O
for	O
the	O
microbicidal	O
effects	O
of	O
activated	O
human	B-cell_type
polymorphonuclear	I-cell_type
leukocytes	I-cell_type
.	O

Treatment	O
of	O
a	O
T-lymphocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
with	O
micromolar	O
concentrations	O
of	O
HOCl	O
promoted	O
the	O
appearance	O
of	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
(	O
the	O
heterodimer	B-protein
p50/p65	I-protein
)	O
in	O
the	O
nucleus	O
of	O
the	O
cells	O
,	O
even	O
in	O
the	O
absence	O
of	O
de	O
novo	O
protein	O
synthesis	O
.	O

Western	O
blot	O
analysis	O
of	O
the	O
NF-kappaB	B-protein
inhibitory	I-protein
subunits	I-protein
(	O
IkappaB	B-protein
)	O
demonstrated	O
that	O
both	O
IkappaB	B-protein
-alpha	O
proteolysis	O
and	O
p105	B-protein
processing	O
were	O
induced	O
by	O
the	O
treatment	O
.	O

NF-kappaB	B-protein
activation	O
was	O
very	O
effective	O
when	O
cells	O
were	O
subjected	O
to	O
hyperthermia	O
before	O
being	O
treated	O
with	O
HOCl	O
.	O

Various	O
antioxidants	O
,	O
such	O
as	O
pyrrolidine	O
dithiocarbamate	O
,	O
p-bromophenacyl-bromide	O
and	O
nordihydroguaiaretic	O
acid	O
could	O
strongly	O
reduce	O
NF-kappaB	B-protein
translocation	O
,	O
demonstrating	O
the	O
importance	O
of	O
oxidative	O
species	O
in	O
the	O
transduction	O
mechanism	O
.	O

Moreover	O
,	O
ACH-2	B-cell_line
cells	I-cell_line
treated	O
with	O
HOCl	O
or	O
H2O2	O
released	O
tumour	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
in	O
the	O
supernatants	O
.	O

The	O
importance	O
of	O
TNF-alpha	B-protein
release	O
in	O
NF-kappaB	B-protein
induction	O
by	O
HOCl	O
or	O
H2O2	O
was	O
demonstrated	O
by	O
the	O
fact	O
that	O
:	O
(	O
1	O
)	O
the	O
nuclear	O
appearance	O
of	O
NF-kappaB	B-protein
was	O
promoted	O
in	O
untreated	B-cell_line
cells	I-cell_line
;	O
and	O
(	O
2	O
)	O
synergism	O
between	O
TNF-alpha	B-protein
and	O
HOCl	O
was	O
detected	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
HOCl	O
should	O
be	O
considered	O
as	O
an	O
oxidative	O
species	O
capable	O
of	O
inducing	O
NF-kappaB	B-protein
in	O
a	O
T-lymphocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
through	O
a	O
transduction	O
mechanism	O
involving	O
ROS	O
,	O
and	O
having	O
a	O
long-distance	O
effect	O
through	O
subsequent	O
TNF-alpha	B-protein
release	O
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
321	NULL
,	NULL
777-785	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
777	NULL
Activation	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
by	NULL
hypochlorous	NULL
acid	NULL
Sonia	NULL
SCHOONBROODT*	NULL
,	NULL
Sylvie	NULL
LEGRAND-POELS*	NULL
,	NULL
Martin	NULL
BEST-BELPOMMEf	NULL
and	NULL
Jacques	NULL
PIETTE*f	NULL
*Laboratory	NULL
of	NULL
Virology	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
B23	NULL
,	NULL
University	NULL
of	NULL
Liége	NULL
,	NULL
B-4000	NULL
Liége	NULL
,	NULL
Belgium	NULL
,	NULL
and	NULL
fLaboratory	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Genetics	NULL
,	NULL
URA	NULL
CNRS	NULL
1135	NULL
,	NULL
Université	NULL
Pierre	NULL
et	NULL
Marie	NULL
Curie	NULL
,	NULL
F-75230	NULL
Paris	NULL
Cedex	NULL
05	NULL
,	NULL
France	NULL
Reactive	NULL
oxygen	NULL
species	NULL
(	NULL
ROS	NULL
)	NULL
such	NULL
as	NULL
hydrogen	NULL
peroxide	NULL
serve	NULL
as	NULL
second	NULL
messengers	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
hence	NULL
in	NULL
the	NULL
activation	NULL
and	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

During	NULL
inflammatory	NULL
reactions	NULL
,	NULL
many	NULL
oxidative	NULL
species	NULL
are	NULL
produced	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
hypochlorous	NULL
acid	NULL
(	NULL
HOCI	NULL
)	NULL
,	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
microbicidal	NULL
effects	NULL
of	NULL
activated	NULL
human	NULL
polymorpho-nuclear	NULL
leukocytes	NULL
.	NULL

Treatment	NULL
of	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
with	NULL
micromolar	NULL
concentrations	NULL
of	NULL
HOC	NULL
]	NULL
promoted	NULL
the	NULL
appearance	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
the	NULL
heterodimer	NULL
p50/p65	NULL
)	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitory	NULL
subunits	NULL
(	NULL
IxB	NULL
)	NULL
demonstrated	NULL
that	NULL
both	NULL
IxB-	NULL
«	NULL
proteolysis	NULL
and	NULL
p105	NULL
processing	NULL
were	NULL
induced	NULL
by	NULL
the	NULL
treatment	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
very	NULL
effective	NULL
when	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
hyperthermia	NULL
before	NULL
being	NULL
treated	NULL
with	NULL
HOC	NULL
.	NULL

Various	NULL
antioxidants	NULL
,	NULL
such	NULL
as	NULL
pyrr-olidine	NULL
dithiocarbamate	NULL
,	NULL
p-bromophenacyl-bromide	NULL
and	NULL
nordihydroguaiaretic	NULL
acid	NULL
could	NULL
strongly	NULL
reduce	NULL
NF-KB	NULL
translocation	NULL
,	NULL
demonstrating	NULL
the	NULL
importance	NULL
of	NULL
oxidative	NULL
species	NULL
in	NULL
the	NULL
transduction	NULL
mechanism	NULL
.	NULL

Moreover	NULL
,	NULL
ACH-2	NULL
cells	NULL
treated	NULL
with	NULL
HOC	NULL
]	NULL
or	NULL
H	NULL
,	NULL
O	NULL
,	NULL
released	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
in	NULL
the	NULL
supernatants	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
TNF-z	NULL
release	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
HOC	NULL
or	NULL
H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
promoted	NULL
in	NULL
untreated	NULL
cells	NULL
;	NULL
and	NULL
(	NULL
2	NULL
)	NULL
synergism	NULL
between	NULL
TNF-a	NULL
and	NULL
HOC	NULL
]	NULL
was	NULL
detected	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
HOC	NULL
]	NULL
should	NULL
be	NULL
considered	NULL
as	NULL
an	NULL
oxidative	NULL
species	NULL
capable	NULL
of	NULL
inducing	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
through	NULL
a	NULL
transduction	NULL
mechanism	NULL
involving	NULL
ROS	NULL
,	NULL
and	NULL
having	NULL
a	NULL
long-distance	NULL
effect	NULL
through	NULL
subsequent	NULL
TNF-	NULL
@	NULL
release	NULL
.	NULL

INTRODUCTION	NULL
One	NULL
of	NULL
the	NULL
key	NULL
experimental	NULL
results	NULL
concerning	NULL
the	NULL
role	NULL
of	NULL
reactive	NULL
oxygen	NULL
species	NULL
(	NULL
ROS	NULL
)	NULL
in	NULL
gene	NULL
expression	NULL
is	NULL
the	NULL
elucidation	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
complex	NULL
as	NULL
a	NULL
transcriptional	NULL
factor	NULL
[	NULL
1	NULL
]	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
[	NULL
2-4	NULL
]	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
related	NULL
to	NULL
the	NULL
proto-oncogene	NULL
c-rel	NULL
(	NULL
reviewed	NULL
in	NULL
[	NULL
5	NULL
]	NULL
and	NULL
[	NULL
6	NULL
]	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
p52	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
Rel	NULL
A	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
Rel	NULL
B	NULL
[	NULL
7-10	NULL
]	NULL
.	NULL

The	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
associate	NULL
to	NULL
form	NULL
a	NULL
variety	NULL
of	NULL
homo-and	NULL
hetero-dimers	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
a	NULL
series	NULL
of	NULL
related	NULL
DNA	NULL
target	NULL
sites	NULL
,	NULL
collectively	NULL
called	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
[	NULL
11	NULL
]	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
dimeric	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
are	NULL
stored	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
non-stimulated	NULL
cells	NULL
as	NULL
inactive	NULL
complexes	NULL
,	NULL
as	NULL
a	NULL
result	NULL
of	NULL
interaction	NULL
with	NULL
a	NULL
group	NULL
of	NULL
inhibitory	NULL
proteins	NULL
,	NULL
collectively	NULL
known	NULL
as	NULL
IB	NULL
[	NULL
12	NULL
]	NULL
.	NULL

NF-	NULL
«	NULL
B1	NULL
and	NULL
NF-	NULL
«	NULL
B2	NULL
are	NULL
initially	NULL
synthesized	NULL
as	NULL
large	NULL
precursors	NULL
of	NULL
105	NULL
and	NULL
100	NULL
kDa	NULL
in	NULL
size	NULL
respectively	NULL
[	NULL
13-15	NULL
]	NULL
.	NULL

These	NULL
precursors	NULL
do	NULL
not	NULL
bind	NULL
DNA	NULL
,	NULL
but	NULL
they	NULL
can	NULL
interact	NULL
with	NULL
other	NULL
Rel-related	NULL
proteins	NULL
and	NULL
function	NULL
in	NULL
an	NULL
IxB-like	NULL
fashion	NULL
by	NULL
sequestering	NULL
various	NULL
Rel-related	NULL
protein	NULL
homo-	NULL
and	NULL
hetero-dimers	NULL
in	NULL
the	NULL
cytoplasm	NULL
[	NULL
16,17	NULL
]	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
p105	NULL
and	NULL
p100	NULL
precursors	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
mature	NULL
DNA-binding	NULL
subunits	NULL
and	NULL
the	NULL
release	NULL
of	NULL
the	NULL
active	NULL
Rel-related	NULL
protein	NULL
dimers	NULL
containing	NULL
p50	NULL
and	NULL
p52	NULL
respectively	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
processing	NULL
of	NULL
both	NULL
precursors	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
and	NULL
can	NULL
be	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
[	NULL
16	NULL
]	NULL
.	NULL

Submitting	NULL
T-lymphocytes	NULL
to	NULL
oxidative	NULL
stress	NULL
,	NULL
as	NULL
mimicked	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
extracellular	NULL
H,0	NULL
,	NULL
,	NULL
induces	NULL
the	NULL
nuclear	NULL
appearance	NULL
and	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
[	NULL
1	NULL
]	NULL
,	NULL
followed	NULL
by	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
proviral	NULL
DNA	NULL
in	NULL
cells	NULL
non-productively	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
[	NULL
18	NULL
]	NULL
.	NULL

Presumably	NULL
,	NULL
the	NULL
mechanism	NULL
involves	NULL
passive	NULL
diffusion	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
through	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

There	NULL
,	NULL
it	NULL
indirectly	NULL
triggers	NULL
the	NULL
controlled	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxB	NULL
molecules	NULL
[	NULL
19,20	NULL
]	NULL
.	NULL

The	NULL
transduction	NULL
mechanism	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
is	NULL
still	NULL
poorly	NULL
understood	NULL
,	NULL
but	NULL
seems	NULL
to	NULL
implicate	NULL
a	NULL
series	NULL
of	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
the	NULL
T-cell	NULL
tyrosine	NULL
kinase	NULL
ZAP-70	NULL
[	NULL
21	NULL
]	NULL
,	NULL
which	NULL
is	NULL
responsive	NULL
to	NULL
H,0	NULL
,	NULL
treatment	NULL
and	NULL
requires	NULL
the	NULL
expression	NULL
of	NULL
CD3	NULL
for	NULL
the	NULL
response	NULL
.	NULL

Moreover	NULL
,	NULL
ZAP-70	NULL
is	NULL
known	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
£	NULL
and	NULL
e	NULL
chains	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
after	NULL
treatment	NULL
with	NULL
H,0	NULL
,	NULL
[	NULL
22,23	NULL
]	NULL
.	NULL

Phagocytic	NULL
cells	NULL
produce	NULL
a	NULL
number	NULL
of	NULL
ROS	NULL
,	NULL
all	NULL
derived	NULL
from	NULL
the	NULL
reduction	NULL
of	NULL
molecular	NULL
oxygen	NULL
to	NULL
superoxide	NULL
anion	NULL
catalysed	NULL
by	NULL
an	NULL
NADPH	NULL
oxidase	NULL
(	NULL
see	NULL
[	NULL
24	NULL
]	NULL
for	NULL
review	NULL
)	NULL
.	NULL

Neutrophils	NULL
(	NULL
polymorphonuclear	NULL
cells	NULL
)	NULL
and	NULL
eosinophils	NULL
,	NULL
but	NULL
not	NULL
mature	NULL
macrophages	NULL
,	NULL
upon	NULL
stimulation	NULL
release	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
)	NULL
into	NULL
phagolysosomes	NULL
or	NULL
into	NULL
the	NULL
extracellular	NULL
medium	NULL
[	NULL
25	NULL
]	NULL
.	NULL

MPO	NULL
from	NULL
neutrophils	NULL
catalyses	NULL
the	NULL
reaction	NULL
of	NULL
H	NULL
,	NULL
O	NULL
with	NULL
CI	NULL
ions	NULL
to	NULL
produce	NULL
hypochlorous	NULL
acid	NULL
(	NULL
HOC	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
eosinophil	NULL
MPO	NULL
preferentially	NULL
uses	NULL
Br	NULL
,	NULL
ions	NULL
even	NULL
though	NULL
the	NULL
CI	NULL
ion	NULL
concentration	NULL
is	NULL
1000-fold	NULL
higher	NULL
in	NULL
plasma	NULL
[	NULL
26	NULL
]	NULL
.	NULL

HOC	NULL
can	NULL
react	NULL
with	NULL
amines	NULL
to	NULL
produce	NULL
chloramines	NULL
and	NULL
N-chlorinated	NULL
derivatives	NULL
which	NULL
have	NULL
long	NULL
lifetimes	NULL
in	NULL
plasma	NULL
[	NULL
27	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
MPO-generated	NULL
HOC	NULL
and	NULL
N-chloramines	NULL
may	NULL
represent	NULL
the	NULL
most	NULL
Abbreviations	NULL
used	NULL
:	NULL
BPB	NULL
,	NULL
p-bromophenacyl-bromide	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
HIV-1	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
;	NULL
IL-1	NULL
,	NULL
PLA2	NULL
,	NULL
phospholipase	NULL
AZ	NULL
;	NULL
ROS	NULL
,	NULL
reactive	NULL
oxygen	NULL
species	NULL
;	NULL
TNF-a	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
MPO	NULL
,	NULL
myeloperoxidase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidinge-dithiocarbamate	NULL
;	NULL
EASIA	NULL
,	NULL
enzyme	NULL
amplified	NULL
sensitivity	NULL
immunoassay	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

7178	NULL
S.	NULL
Schoonbroodt	NULL
and	NULL
others	NULL
important	NULL
oxidants	NULL
produced	NULL
by	NULL
activated	NULL
neutrophils	NULL
,	NULL
and	NULL
there	NULL
is	NULL
now	NULL
a	NULL
growing	NULL
body	NULL
of	NULL
evidence	NULL
suggesting	NULL
that	NULL
they	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
inflammation	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
inflammatory	NULL
bowel	NULL
diseases	NULL
[	NULL
28	NULL
]	NULL
.	NULL

Since	NULL
it	NULL
is	NULL
now	NULL
clearly	NULL
established	NULL
that	NULL
micromolar	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
modulate	NULL
cell	NULL
function	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
(	NULL
see	NULL
[	NULL
2	NULL
]	NULL
and	NULL
[	NULL
29	NULL
]	NULL
for	NULL
reviews	NULL
)	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
investigate	NULL
whether	NULL
low	NULL
concentrations	NULL
of	NULL
HOC	NULL
]	NULL
can	NULL
function	NULL
as	NULL
a	NULL
mediator	NULL
in	NULL
cell	NULL
activation	NULL
,	NULL
with	NULL
special	NULL
emphasis	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
,	NULL
which	NULL
is	NULL
redox	NULL
regulated	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
an	NULL
important	NULL
oxidant	NULL
such	NULL
as	NULL
HOC	NULL
]	NULL
can	NULL
,	NULL
with	NULL
a	NULL
slow	NULL
kinetic	NULL
rate	NULL
,	NULL
also	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
p50/p65	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
through	NULL
proteolysis	NULL
of	NULL
IxB-	NULL
«	NULL
and	NULL
p105	NULL
inhibitors	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
HOC	NULL
contributes	NULL
to	NULL
the	NULL
release	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
in	NULL
cell	NULL
supernatants	NULL
capable	NULL
of	NULL
propagating	NULL
activation	NULL
to	NULL
non-induced	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
reagents	NULL
The	NULL
ACH-2	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
NIH	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
U.S.A.	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
cultivated	NULL
in	NULL
RPMI	NULL
1640	NULL
+	NULL
Glutamax	NULL
I	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
(	NULL
all	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
seeded	NULL
in	NULL
fresh	NULL
medium	NULL
12-24	NULL
h	NULL
before	NULL
any	NULL
experiment	NULL
.	NULL

Chemicals	NULL
All	NULL
chemicals	NULL
were	NULL
of	NULL
reagent	NULL
grade	NULL
and	NULL
were	NULL
obtained	NULL
from	NULL
UCB	NULL
(	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
or	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

NaCIO	NULL
was	NULL
purchased	NULL
from	NULL
Aldrich	NULL
(	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
and	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
hypochlorous	NULL
acid	NULL
(	NULL
HOC	NULL
]	NULL
)	NULL
by	NULL
adjusting	NULL
the	NULL
pH	NULL
to	NULL
6.85	NULL
with	NULL
diluted	NULL
H	NULL
,	NULL
SO	NULL
,	NULL
immediately	NULL
before	NULL
use	NULL
.	NULL

HOC	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
a	NULL
molar	NULL
absorption	NULL
coefficient	NULL
of	NULL
100	NULL
at	NULL
235	NULL
nm	NULL
[	NULL
30	NULL
]	NULL
.	NULL

At	NULL
pH	NULL
6.85	NULL
,	NULL
HOC	NULL
]	NULL
is	NULL
partly	NULL
ionized	NULL
to	NULL
hypochlorite	NULL
anion	NULL
,	NULL
CIO	NULL
,	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
HOCI/CIO-~	NULL
of	NULL
x	NULL
1.8:1	NULL
.	NULL

Generation	NULL
of	NULL
oxidative	NULL
stress	NULL
ACH-2	NULL
cells	NULL
,	NULL
at	NULL
6	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
,	NULL
were	NULL
cultivated	NULL
in	NULL
25cm	NULL
``	NULL
culture	NULL
flasks	NULL
before	NULL
being	NULL
treated	NULL
with	NULL
HOC	NULL
]	NULL
(	NULL
0-500	NULL
LM	NULL
)	NULL
.	NULL

Before	NULL
treatment	NULL
with	NULL
HOC	NULL
]	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
resupended	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
in	NULL
the	NULL
medium	NULL
without	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

At	NULL
30	NULL
min	NULL
after	NULL
HOC	NULL
]	NULL
addition	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
refed	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
(	NULL
4-5	NULL
)	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
subsequently	NULL
harvested	NULL
at	NULL
various	NULL
times	NULL
(	NULL
between	NULL
30	NULL
and	NULL
180	NULL
min	NULL
)	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
electrophoretic	NULL
mobility-shift	NULL
analysis	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
counted	NULL
and	NULL
cytotoxicity	NULL
was	NULL
estimated	NULL
using	NULL
Trypan	NULL
Blue	NULL
exclusion	NULL
.	NULL

Nuclear	NULL
protein	NULL
extraction	NULL
The	NULL
method	NULL
used	NULL
for	NULL
the	NULL
extraction	NULL
of	NULL
nuclear	NULL
proteins	NULL
is	NULL
described	NULL
elsewhere	NULL
[	NULL
31	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
at	NULL
various	NULL
times	NULL
after	NULL
the	NULL
oxidative	NULL
stress	NULL
,	NULL
(	NULL
3-5	NULL
)	NULL
x	NULL
10°	NULL
ACH-2	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
cold	NULL
PBS	NULL
and	NULL
centrifuged	NULL
at	NULL
15000	NULL
g	NULL
for	NULL
15	NULL
s	NULL
,	NULL
resuspended	NULL
in	NULL
100-400	NULL
wl	NULL
of	NULL
cold	NULL
hypotonic	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
Hepes/KOH/2	NULL
mM	NULL
MgC1	NULL
,	NULL
/0.1	NULL
mMEDTA/10	NULL
mMKCl/1	NULL
mM	NULL
dithiothreitol	NULL
{	NULL
DTT	NULL
)	NULL
/	NULL
0.5	NULL
mM	NULL
PMSF	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
]	NULL
,	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
then	NULL
vortexed	NULL
and	NULL
centrifuged	NULL
at	NULL
15000	NULL
g	NULL
for	NULL
30	NULL
s.	NULL
Aliquots	NULL
of	NULL
supernatant	NULL
,	NULL
containing	NULL
the	NULL
cytoplasmic	NULL
proteins	NULL
,	NULL
were	NULL
quickly	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

The	NULL
pellets	NULL
of	NULL
nuclei	NULL
were	NULL
gently	NULL
resuspended	NULL
in	NULL
15	NULL
wl	NULL
of	NULL
cold	NULL
saline	NULL
buffer	NULL
[	NULL
50	NULL
mM	NULL
Hepes/KOH/50	NULL
mM	NULL
KCI1/300	NULL
mM	NULL
NaCl	NULL
mM	NULL
EDTA/10	NULL
%	NULL
(	NULL
w	NULL
/v	NULL
)	NULL
glycerol	NULL
/1	NULL
mM	NULL
DTT/0.5	NULL
mM	NULL
PMSF	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
]	NULL
and	NULL
left	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
centrifugation	NULL
(	NULL
15000	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
)	NULL
,	NULL
aliquots	NULL
of	NULL
supernatant	NULL
,	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
,	NULL
were	NULL
kept	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
measured	NULL
with	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
(	NULL
BCA	NULL
)	NULL
kit	NULL
supplied	NULL
by	NULL
Pierce	NULL
(	NULL
Rockford	NULL
,	NULL
IL	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
The	NULL
EMSA	NULL
method	NULL
used	NULL
is	NULL
that	NULL
described	NULL
in	NULL
[	NULL
32	NULL
]	NULL
,	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
0.2	NULL
ng	NULL
of	NULL
**P-labelled	NULL
oligonucleotidic	NULL
probe	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
BSA	NULL
and	NULL
1.25	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Benelux	NULL
,	NULL
Rozendaal	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
in	NULL
20	NULL
mM	NULL
Hepes/KOH/75	NULL
mM	NULL
NaCl/1	NULL
mM	NULL
EDTA/5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
mM	NULL
MgCl	NULL
,	NULL
/1	NULL
mM	NULL
DTT	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
buffer	NULL
(	NULL
final	NULL
volume	NULL
10	NULL
wl	NULL
)	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
then	NULL
resolved	NULL
on	NULL
a	NULL
non-denaturing	NULL
6	NULL
%	NULL
polyacrylamide	NULL
(	NULL
4	NULL
%	NULL
for	NULL
supershifts	NULL
)	NULL
gel	NULL
run	NULL
for	NULL
4	NULL
h	NULL
at	NULL
180	NULL
V	NULL
in	NULL
TBE	NULL
{	NULL
0.5	NULL
x	NULL
[	NULL
2.5	NULL
mM	NULL
Tris/2.5	NULL
mM	NULL
H	NULL
,	NULL
BO	NULL
,	NULL
/2	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.5	NULL
)	NULL
]	NULL
}	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
autoradiographed	NULL
on	NULL
a	NULL
Fuji	NULL
X-ray	NULL
film	NULL
(	NULL
General	NULL
Electrics	NULL
,	NULL
Antwerp	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabelled	NULL
probe	NULL
(	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
)	NULL
was	NULL
added	NULL
in	NULL
excess	NULL
(	NULL
50x	NULL
)	NULL
in	NULL
the	NULL
binding	NULL
buffer	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Eurogentec	NULL
,	NULL
Seraing	NULL
,	NULL
Belgium	NULL
)	NULL
was	NULL
labelled	NULL
by	NULL
infilling	NULL
with	NULL
the	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
(	NULL
Bochringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
as	NULL
described	NULL
elsewhere	NULL
[	NULL
32	NULL
]	NULL
.	NULL

Probe	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
was	NULL
labelled	NULL
with	NULL
3	NULL
4yCi	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
and	NULL
[	NULL
«	NULL
-**P	NULL
]	NULL
dCTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Du	NULL
Pont	NULL
De	NULL
Nemours	NULL
International	NULL
,	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
and	NULL
unlabelled	NULL
dTTP	NULL
and	NULL
dGTP	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
then	NULL
purified	NULL
on	NULL
a	NULL
Sephadex	NULL
G-25	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Benelux	NULL
)	NULL
column	NULL
and	NULL
stored	NULL
at	NULL
-20	NULL
°C	NULL
until	NULL
use	NULL
.	NULL

Specific	NULL
radioactivity	NULL
was	NULL
always	NULL
>	NULL
10°	NULL
c.p.m./ug	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
probes	NULL
used	NULL
in	NULL
this	NULL
work	NULL
were	NULL
:	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
:	NULL
5-GGTTACAAGGGACTTTCCGCTG	NULL
TGTTCCCTGAAAGGCGACGGTT-Y	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
:	NULL
5-GGTTACAACTCACTTTCCGCTG	NULL
TGTTGAGTGAAAGGCGACGGTT-S	NULL
AP-1	NULL
probe	NULL
:	NULL
5-CTAGAGGTGTCTGACTCATGCTTTA	NULL
TCCACAGACTGAGTACGAAATTCGA-S	NULL
Exposure	NULL
of	NULL
ACH-2	NULL
cells	NULL
to	NULL
hyperthermia	NULL
Exponentially	NULL
growing	NULL
ACH-2	NULL
cells	NULL
(	NULL
0.6	NULL
x	NULL
10°	NULL
per	NULL
ml	NULL
of	NULL
complete	NULL
culture	NULL
medium	NULL
)	NULL
were	NULL
placed	NULL
in	NULL
a	NULL
water	NULL
bath	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
with	NULL
the	NULL
temperature	NULL
increased	NULL
to	NULL
42	NULL
°C	NULL
over	NULL
a	NULL
period	NULL
of	NULL
30	NULL
min	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
then	NULL
maintained	NULL
at	NULL
42°C	NULL
for	NULL
40	NULL
min	NULL
before	NULL
being	NULL
slowly	NULL
cooled	NULL
down	NULL
to	NULL
37	NULL
°C	NULL
within	NULL
30	NULL
min	NULL
.	NULL

At	NULL
each	NULL
time	NULL
point	NULL
during	NULL
the	NULL
various	NULL
phases	NULL
,	NULL
aliquots	NULL
of	NULL
(	NULL
4-5	NULL
)	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
taken	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
assay	NULL
.	NULL

ACH-2	NULL
cells	NULL
in	NULL
culture	NULL
medium	NULL
made	NULL
hyperthermic	NULL
following	NULL
this	NULL
procedure	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
an	NULL
oxidative	NULL
stress	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
(	NULL
100-300	NULL
LM	NULL
)	NULL
.	NULL

Between	NULL
30	NULL
and	NULL
180	NULL
min	NULL
after	NULL
treatment	NULL
with	NULL
HOC	NULL
]	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
analysis	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
hypochlorous	NULL
acid	NULL
779	NULL
Exposure	NULL
of	NULL
ACH-2	NULL
cells	NULL
to	NULL
TNF-	NULL
«	NULL
before	NULL
HOCI	NULL
TNF-a	NULL
(	NULL
Boehringer	NULL
,	NULL
Germany	NULL
)	NULL
(	NULL
0-1000	NULL
units/ml	NULL
)	NULL
was	NULL
directly	NULL
added	NULL
to	NULL
complete	NULL
media	NULL
,	NULL
using	NULL
0.6	NULL
x	NULL
10°	NULL
ACH-2	NULL
cells	NULL
per	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
.	NULL

At	NULL
90	NULL
min	NULL
after	NULL
treatment	NULL
with	NULL
TNF-a	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
an	NULL
oxidative	NULL
stress	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
(	NULL
100-300	NULL
zM	NULL
)	NULL
,	NULL
and	NULL
3	NULL
h	NULL
later	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
analysis	NULL
.	NULL

Western	NULL
blotting	NULL
The	NULL
IkB-a	NULL
subunit	NULL
,	NULL
p65	NULL
and	NULL
p105-p50	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
specific	NULL
antibodies	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
various	NULL
times	NULL
after	NULL
HOCl-mediated	NULL
treatment	NULL
by	NULL
hypotonic	NULL
lysis	NULL
,	NULL
pelleting	NULL
of	NULL
the	NULL
nuclei	NULL
and	NULL
collection	NULL
of	NULL
the	NULL
supernatant	NULL
fraction	NULL
[	NULL
32	NULL
]	NULL
.	NULL

Cytoplasmic	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
a	NULL
loading	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
Tris/HCl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
/1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
SDS	NULL
$	NULL
/25	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol/0.1	NULL
mM	NULL
2-mercaptocthanol/0.03	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Brom-ophenol	NULL
Blue	NULL
]	NULL
,	NULL
boiled	NULL
and	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
-polyacrylamide	NULL
gel	NULL
and	NULL
electro-transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
incubated	NULL
in	NULL
primary	NULL
antibody	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
(	NULL
1:2000	NULL
dilution	NULL
)	NULL
and	NULL
in	NULL
peroxidase-comjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
1	NULL
:	NULL
250	NULL
dilution	NULL
)	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
and	NULL
finally	NULL
analysed	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
,	NULL
Slough	NULL
,	NULL
U.K.	NULL
)	NULL
using	NULL
Fuji	NULL
X-ray	NULL
films	NULL
.	NULL

TNF-	NULL
«	NULL
and	NULL
(	NULL
IL-1/	NULL
)	NULL
detection	NULL
The	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
or	NULL
IL-1	NULL
}	NULL
in	NULL
cell	NULL
supernatants	NULL
taken	NULL
from	NULL
ACH-2	NULL
cells	NULL
,	NULL
pretreated	NULL
with	NULL
either	NULL
100	NULL
4M	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
200	NULL
gM	NULL
HOC	NULL
]	NULL
,	NULL
was	NULL
quantitatively	NULL
assayed	NULL
by	NULL
immunoassays	NULL
[	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
#	NULL
enzyme	NULL
amplified	NULL
sensitivity	NULL
immunoassay	NULL
(	NULL
EASIA	NULL
)	NULL
,	NULL
Medgenix	NULL
,	NULL
Fleurus	NULL
,	NULL
Belgium	NULL
]	NULL
.	NULL

Cytokine	NULL
measurements	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
values	NULL
were	NULL
directly	NULL
compared	NULL
with	NULL
an	NULL
internal	NULL
standardization	NULL
curve	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
the	NULL
EASIA	NULL
tests	NULL
was	NULL
3	NULL
and	NULL
2	NULL
pg/ml	NULL
for	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
}	NULL
respectively	NULL
.	NULL

RESULTS	NULL
HOCGI	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
binding	NULL
factor	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
H	NULL
,	NULL
O	NULL
,	NULL
-mediated	NULL
oxidative	NULL
stress	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
strongly	NULL
activate	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
lymphocytes	NULL
or	NULL
in	NULL
various	NULL
transformed	NULL
cell	NULL
lines	NULL
[	NULL
1,33	NULL
]	NULL
.	NULL

We	NULL
performed	NULL
EMSA	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
HOCl-mediated	NULL
oxidative	NULL
stress	NULL
could	NULL
lead	NULL
to	NULL
a	NULL
similar	NULL
induction	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
.	NULL

Within	NULL
120	NULL
min	NULL
following	NULL
the	NULL
oxidative	NULL
stress	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
,	NULL
a	NULL
factor	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B	NULL
sites	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
ACH-2	NULL
cells	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
induction	NULL
was	NULL
directly	NULL
related	NULL
to	NULL
the	NULL
concentration	NULL
of	NULL
HOC	NULL
]	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
phosphorimaging	NULL
revealed	NULL
that	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
complex	NULL
varied	NULL
with	NULL
HOC	NULL
concentration	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
;	NULL
maximal	NULL
induction	NULL
was	NULL
observed	NULL
between	NULL
200	NULL
and	NULL
250	NULL
aM	NULL
HOC	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
where	NULL
a	NULL
maximal	NULL
stimulation	NULL
factor	NULL
of	NULL
10.5	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

At	NULL
300	NULL
gM	NULL
HOC	NULL
]	NULL
,	NULL
the	NULL
band	NULL
intensity	NULL
decreased	NULL
,	NULL
probably	NULL
due	NULL
to	NULL
a	NULL
cytotoxic	NULL
effect	NULL
.	NULL

The	NULL
specificity	NULL
for	NULL
these	NULL
«	NULL
B	NULL
sites	NULL
was	NULL
shown	NULL
by	NULL
the	NULL
disappearance	NULL
of	NULL
this	NULL
complex	NULL
through	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
probe	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
AP-1	NULL
probe	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Another	NULL
complex	NULL
,	NULL
showing	NULL
greater	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Figures	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
seemed	NULL
to	NULL
be	NULL
induced	NULL
with	NULL
the	NULL
same	NULL
kinetic	NULL
characteristics	NULL
,	NULL
but	NULL
was	NULL
not	NULL
competed	NULL
out	NULL
by	NULL
the	NULL
wild-type	NULL
probe	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
o	NULL
o	NULL
o	NULL
o	NULL
o	NULL
o	NULL
im	NULL
C	NULL
i	NULL
o	NULL
HOCI	NULL
(	NULL
@	NULL
M	NULL
)	NULL
o	NULL
-	NULL
m	NULL
®	NULL
a_	NULL
®	NULL
PMA	NULL
>	NULL
0	NULL
+	NULL
-	NULL
t	NULL
toot	NULL
oto	NULL
$	NULL
/	NULL
-	NULL
«	NULL
%	NULL
=	NULL
=	NULL
o	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
uM	NULL
)	NULL
£	NULL
Specific	NULL
j	NULL
u	NULL
complex	NULL
ii	NULL
jemi	NULL
S	NULL
m	NULL
``	NULL
T	NULL
o	NULL
O	NULL
NM	NULL
Figure	NULL
1	NULL
-	NULL
NF-xB	NULL
Induction	NULL
In	NULL
ACH-2	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
HOCI	NULL
Effect	NULL
of	NULL
HOCI	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
ACH-2	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
a	NULL
nuclear	NULL
«	NULL
B	NULL
enhancer	NULL
DNA-binding	NULL
protein	NULL
by	NULL
treatment	NULL
of	NULL
ACH-2	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
HOCI	NULL
(	NULL
0-300	NULL
M	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
1	NULL
M	NULL
)	NULL
and	NULL
H0	NULL
,	NULL
(	NULL
100	NULL
M	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
120	NULL
min	NULL
after	NULL
the	NULL
reaction	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
proteins	NULL
were	NULL
mixed	NULL
with	NULL
a	NULL
*P-labelled	NULL
probe	NULL
encompassing	NULL
the	NULL
xB	NULL
elements	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
on	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
electrophoresed	NULL
at	NULL
150	NULL
V.	NULL
An	NULL
autoradiogram	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
and	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
.	NULL

the	NULL
latter	NULL
complex	NULL
did	NULL
not	NULL
seem	NULL
to	NULL
involve	NULL
a	NULL
nuclear	NULL
factor	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
specific	NULL
«	NULL
B	NULL
complex	NULL
induced	NULL
by	NULL
HOC	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
induced	NULL
by	NULL
phorbol	NULL
12-myristate	NULL
l3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
a	NULL
similar	NULL
concentration	NULL
range	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
while	NULL
HOC	NULL
]	NULL
should	NULL
be	NULL
considered	NULL
as	NULL
an	NULL
oxidative	NULL
species	NULL
capable	NULL
of	NULL
inducing	NULL
NF-kB	NULL
,	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
less	NULL
efficient	NULL
than	NULL
with	NULL
other	NULL
ROS	NULL
such	NULL
as	NULL
H	NULL
,	NULL
O	NULL
,	NULL
[	NULL
1,33	NULL
]	NULL
or	NULL
singlet	NULL
oxygen	NULL
[	NULL
34,35	NULL
]	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
HOCl-activated	NULL
DNA-protein	NULL
complex	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
further	NULL
investigated	NULL
in	NULL
supershift	NULL
experiments	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
the	NULL
HOCI-activated	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
could	NULL
react	NULL
with	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
DNA-binding	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
well	NULL
as	NULL
with	NULL
c-Rel	NULL
.	NULL

The	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
sera	NULL
clearly	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
characteristic	NULL
supershift	NULL
of	NULL
the	NULL
retarded	NULL
complex	NULL
,	NULL
demonstrating	NULL
unambiguously	NULL
that	NULL
the	NULL
HOCl-activated	NULL
factor	NULL
is	NULL
p50-	NULL
and	NULL
p65-containing	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

No	NULL
supershift	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
could	NULL
be	NULL
observed	NULL
either	NULL
with	NULL
c-Rel	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
with	NULL
p52	NULL
antibodies	NULL
,	NULL
or	NULL
with	NULL
an	NULL
unrelated	NULL
serum	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
quite	NULL
rapid	NULL
when	NULL
induction	NULL
is	NULL
carried	NULL
out	NULL
with	NULL
various	NULL
membrane-targeting	NULL
mediators	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
phorbol	NULL
ester	NULL
or	NULL
lipopoly-saccharide	NULL
[	NULL
19,20	NULL
]	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
occurs	NULL
in	NULL
a	NULL
similar	NULL
time	NULL
scale	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
treated	NULL
780	NULL
S.	NULL
Schoonbroodt	NULL
and	NULL
others	NULL
§	NULL
g	NULL
WT	NULL
AP-	NULL
]	NULL
Competitor	NULL
*	NULL
7	NULL
50x	NULL
50x	NULL
Serum	NULL
anti-	NULL
p50	NULL
p65	NULL
cRel	NULL
.	NULL

#	NULL
tod	NULL
Specific	NULL
complex	NULL
»	NULL
H	NULL
Figure	NULL
2	NULL
-	NULL
NF-xB	NULL
Induced	NULL
by	NULL
HOCI	NULL
is	NULL
the	NULL
heterodimer	NULL
p50/p6§5	NULL
Immunoreactivity	NULL
of	NULL
the	NULL
HOCl-inducible	NULL
protein-	NULL
«	NULL
B	NULL
enhancer	NULL
complex	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
ACH-2	NULL
cells	NULL
treated	NULL
with	NULL
HOCI	NULL
(	NULL
200	NULL
M	NULL
)	NULL
were	NULL
either	NULL
mixed	NULL
directly	NULL
with	NULL
the	NULL
``	NULL
p-iabelled	NULL
«	NULL
B	NULL
probe	NULL
or	NULL
incubated	NULL
with	NULL
antisera	NULL
specific	NULL
for	NULL
p50	NULL
,	NULL
p65	NULL
or	NULL
c-Rel	NULL
before	NULL
being	NULL
mixed	NULL
with	NULL
the	NULL
°P-labelled	NULL
B	NULL
probe	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
loaded	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
native	NULL
ge	NULL
!	NULL

and	NULL
electrophoresed	NULL
as	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

Competition	NULL
with	NULL
an	NULL
unlabelled	NULL
oligonucleotide	NULL
(	NULL
50	NULL
M	NULL
excess	NULL
)	NULL
,	NULL
encompassing	NULL
NF-KB	NULL
sites	NULL
,	NULL
reveals	NULL
the	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

The	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
could	NULL
not	NULL
be	NULL
competed	NULL
out	NULL
with	NULL
a	NULL
50	NULL
M	NULL
excess	NULL
of	NULL
a	NULL
probe	NULL
encompassing	NULL
the	NULL
AP-1	NULL
element	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
promoter	NULL
.	NULL

WT	NULL
,	NULL
wild-type	NULL
probe	NULL
.	NULL

with	NULL
HOC	NULL
(	NULL
200	NULL
wM	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
various	NULL
time	NULL
points	NULL
(	NULL
between	NULL
0	NULL
and	NULL
300	NULL
min	NULL
)	NULL
before	NULL
being	NULL
analysed	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
xB	NULL
probe	NULL
.	NULL

Figure	NULL
3	NULL
(	NULL
A	NULL
)	NULL
shows	NULL
that	NULL
very	NULL
shortly	NULL
after	NULL
the	NULL
stress	NULL
(	NULL
0-30	NULL
min	NULL
)	NULL
,	NULL
no	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

The	NULL
minimal	NULL
induction	NULL
time	NULL
required	NULL
to	NULL
detect	NULL
a	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
60	NULL
min	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
this	NULL
complex	NULL
still	NULL
being	NULL
observable	NULL
for	NULL
longer	NULL
periods	NULL
up	NULL
to	NULL
300	NULL
min	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

These	NULL
data	NULL
reveal	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
is	NULL
significantly	NULL
slower	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
other	NULL
inducers	NULL
acting	NULL
directly	NULL
at	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
where	NULL
maximal	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
occurred	NULL
within	NULL
5-30	NULL
min	NULL
[	NULL
19,20	NULL
]	NULL
.	NULL

Indeed	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
rather	NULL
similar	NULL
to	NULL
that	NULL
measured	NULL
by	NULL
HOC	NULL
]	NULL
:	NULL
it	NULL
was	NULL
detectable	NULL
after	NULL
60	NULL
min	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
was	NULL
sustained	NULL
up	NULL
to	NULL
300	NULL
min	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Another	NULL
characteristic	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
its	NULL
activation	NULL
by	NULL
a	NULL
post-translational	NULL
mechanism	NULL
involving	NULL
the	NULL
release	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
from	NULL
a	NULL
cytoplasmic	NULL
inactive	NULL
form	NULL
[	NULL
36	NULL
]	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
HOC	NULL
involves	NULL
a	NULL
post-translational	NULL
mechanism	NULL
,	NULL
the	NULL
oxidative	NULL
stress	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

When	NULL
ACH-2	NULL
cells	NULL
alone	NULL
were	NULL
treated	NULL
with	NULL
25	NULL
ug/ml	NULL
CHX	NULL
,	NULL
only	NULL
a	NULL
very	NULL
weak	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
seen	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
NF-KB	NULL
activity	NULL
induced	NULL
by	NULL
HOC	NULL
]	NULL
at	NULL
200	NULL
4M	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
,	NULL
indicating	NULL
that	NULL
up	NULL
to	NULL
150	NULL
min	NULL
after	NULL
the	NULL
stress	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
activated	NULL
by	NULL
a	NULL
post-translational	NULL
mechanism	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

At	NULL
a	NULL
longer	NULL
time	NULL
(	NULL
300	NULL
min	NULL
)	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
band	NULL
was	NULL
decreased	NULL
,	NULL
demonstrating	NULL
that	NULL
part	NULL
of	NULL
the	NULL
induction	NULL
at	NULL
this	NULL
longer	NULL
time	NULL
might	NULL
be	NULL
due	NULL
to	NULL
a	NULL
transcriptional	NULL
mechanism	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
NF-xB	NULL
family	NULL
members	NULL
We	NULL
also	NULL
followed	NULL
the	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
nucleus	NULL
A	NULL
.	NULL

&	NULL
=	NULL
=	NULL
a	NULL
=	NULL
L	NULL
&	NULL
e-	NULL
mo	NULL
s	NULL
s	NULL
<	NULL
n	NULL
S	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
=	NULL
‘	NULL
,	NULL
..=-_	NULL
is	NULL
a	NULL
=-	NULL
-	NULL
mo	NULL
e	NULL
&	NULL
-	NULL
m	NULL
CHX	NULL
.	NULL

0	NULL
.	NULL

o.	NULL
k	NULL
ok	NULL
ok	NULL
ok	NULL
4	NULL
40	NULL
4	NULL
o+	NULL
#	NULL
(	NULL
25	NULL
jig/ml	NULL
)	NULL
Specific	NULL
complex	NULL
inic	NULL
)	NULL
Yah	NULL
tt	NULL
e	NULL
tag	NULL
wass	NULL
Gund	NULL
i	NULL
»	NULL
L	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
B	NULL
.	NULL

<	NULL
&	NULL
&	NULL
l	NULL
Time	NULL
{	NULL
min	NULL
)	NULL
so	NULL
&	NULL
T	NULL
g	NULL
8	NULL
A	NULL
£	NULL
2	NULL
Specific	NULL
complex	NULL
#	NULL
“	NULL
hi—d	NULL
:	NULL
-	NULL
«	NULL
agl	NULL
woud	NULL
need	NULL
mess	NULL
ines	NULL
teeth	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Figure	NULL
3	NULL
Time-course	NULL
experiments	NULL
of	NULL
H,0	NULL
,	NULL
-	NULL
or	NULL
HOCl-medlated	NULL
NF-xB	NULL
Induction	NULL
(	NULL
A	NULL
)	NULL
NF-xB	NULL
activation	NULL
by	NULL
HOCI	NULL
is	NULL
a	NULL
post-transcriptional	NULL
event	NULL
.	NULL

Evolution	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
induced	NULL
in	NULL
ACH-2	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
HOCI	NULL
(	NULL
200	NULL
M	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
taken	NULL
at	NULL
various	NULL
times	NULL
after	NULL
treatment	NULL
(	NULL
0-300	NULL
min	NULL
)	NULL
and	NULL
used	NULL
to	NULL
prepare	NULL
nuclear	NULL
extracts	NULL
to	NULL
be	NULL
analysed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

A	NULL
time-course	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
gg/ml	NULL
CHX	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Time-course	NULL
experiment	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
-mediated	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
M	NULL
H	NULL
,	NULL
O	NULL
,	NULL
Cells	NULL
were	NULL
taken	NULL
at	NULL
various	NULL
times	NULL
after	NULL
the	NULL
treatment	NULL
(	NULL
0-300	NULL
min	NULL
)	NULL
and	NULL
used	NULL
to	NULL
prepare	NULL
nuclear	NULL
extracts	NULL
to	NULL
be	NULL
analysed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

A	NULL
s	NULL
A	NULL
4	NULL
&	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
&	NULL
©	NULL
-~	NULL
-	NULL
46	NULL
IKB	NULL
-JP	NULL
wes	NULL
wos	NULL
30	NULL
B	NULL
.	NULL

|-	NULL
69	NULL
p65	NULL
-	NULL
»	NULL
|uz	NULL
#	NULL
CHP	NULL
ugh	NULL
same	NULL
C.	NULL
e	NULL
s	NULL
a	NULL
&	NULL
£	NULL
&	NULL
'	NULL
c	NULL
#	NULL
=	NULL
=	NULL
p	NULL
105	NULL
--	NULL
-	NULL
66	NULL
50	NULL
-	NULL
»	NULL
®	NULL
L-ai.s	NULL
Figure	NULL
4	NULL
-	NULL
Proteolysis	NULL
of	NULL
Inhibitory	NULL
subunits	NULL
Induced	NULL
by	NULL
HOCI	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
evolution	NULL
of	NULL
the	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
protein	NULL
family	NULL
after	NULL
stress	NULL
mediated	NULL
by	NULL
HOCI	NULL
(	NULL
200	NULL
M	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
!	NULL

«	NULL
B-	NULL
«	NULL
,	NULL
(	NULL
B	NULL
)	NULL
p65	NULL
and	NULL
(	NULL
G	NULL
)	NULL
p50	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
untreated	NULL
cells	NULL
and	NULL
at	NULL
several	NULL
time	NULL
points	NULL
after	NULL
treatment	NULL
with	NULL
HOCI	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
on	NULL
an	NULL
SDS/0	NULL
%	NULL
-polyacrylamide	NULL
gel	NULL
and	NULL
electrophoresed	NULL
before	NULL
being	NULL
transferred	NULL
to	NULL
a	NULL
membrans	NULL
and	NULL
revealed	NULL
by	NULL
luminescence	NULL
.	NULL

(	NULL
Figure	NULL
3A	NULL
)	NULL
in	NULL
connection	NULL
with	NULL
the	NULL
disappearance	NULL
of	NULL
IxB-	NULL
«	NULL
(	NULL
formely	NULL
MAD3	NULL
)	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
HOC	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
NF-KB	NULL
activation	NULL
by	NULL
hypochlorous	NULL
acid	NULL
781	NULL
Hyperthermia	NULL
+	NULL
=	NULL
-	NULL
5	NULL
v	NULL
a	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
o	NULL
o	NULL
o	NULL
8	NULL
&	NULL
2	NULL
&	NULL
a	NULL
a	NULL
&	NULL
0	NULL
a	NULL
0	NULL
HOCI	NULL
(	NULL
1M	NULL
)	NULL
o	NULL
-o	NULL
w	NULL
a	NULL
-	NULL
a	NULL
-	NULL
-o	NULL
o	NULL
ad	NULL
m	NULL
Specific	NULL
iy	NULL
complex	NULL
®	NULL
®	NULL
bes	NULL
woud	NULL
woul	NULL
«	NULL
a	NULL
free	NULL
probe	NULL
-pe	NULL
Figure	NULL
5	NULL
-	NULL
Hyperthermia	NULL
and	NULL
HOCI	NULL
can	NULL
synergistically	NULL
Induce	NULL
NF-xB	NULL
Induction	NULL
of	NULL
a	NULL
nuclear	NULL
NF-xB	NULL
enhancer	NULL
DNA-binding	NULL
protein	NULL
by	NULL
treatment	NULL
of	NULL
ACH-2	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
HOCI	NULL
(	NULL
100-300	NULL
M	NULL
)	NULL
after	NULL
a	NULL
round	NULL
of	NULL
hyperthermia	NULL
at	NULL
42	NULL
°C	NULL
,	NULL
or	NULL
maintained	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Hyperthermia	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
raising	NULL
the	NULL
temperature	NULL
from	NULL
37	NULL
°C	NULL
to	NULL
42	NULL
°C	NULL
over	NULL
a	NULL
period	NULL
of	NULL
30	NULL
min	NULL
and	NULL
maintaining	NULL
cells	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
40	NULL
min	NULL
before	NULL
cooling	NULL
the	NULL
cells	NULL
down	NULL
.	NULL

Samples	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
Figure	NULL
1	NULL
and	NULL
analysed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
-polyacrylamide	NULL
native	NULL
ge	NULL
!	NULL

and	NULL
electrophoresed	NULL
.	NULL

mentioned	NULL
above	NULL
,	NULL
then	NULL
placed	NULL
in	NULL
culture	NULL
medium	NULL
.	NULL

Aliquots	NULL
were	NULL
prepared	NULL
various	NULL
times	NULL
after	NULL
the	NULL
stress	NULL
to	NULL
follow	NULL
the	NULL
disappearance	NULL
of	NULL
I	NULL
«	NULL
kB-	NULL
@	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
both	NULL
untreated	NULL
cells	NULL
and	NULL
at	NULL
very	NULL
short	NULL
times	NULL
after	NULL
the	NULL
stress	NULL
,	NULL
IxB-m-specific	NULL
IgG	NULL
detected	NULL
a	NULL
single	NULL
38	NULL
kDa	NULL
band	NULL
on	NULL
Western	NULL
blots	NULL
.	NULL

Between	NULL
120	NULL
and	NULL
150	NULL
min	NULL
after	NULL
the	NULL
stress	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
IxB-	NULL
«	NULL
decreased	NULL
significantly	NULL
in	NULL
cytoplasm	NULL
,	NULL
coinciding	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
the	NULL
temporal	NULL
relationship	NULL
between	NULL
the	NULL
two	NULL
biochemical	NULL
events	NULL
.	NULL

Similarly	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
cytoplasmic	NULL
content	NULL
of	NULL
p50	NULL
and	NULL
its	NULL
precursor	NULL
p1l05	NULL
revealed	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
p105	NULL
slowly	NULL
decreased	NULL
and	NULL
disappeared	NULL
completely	NULL
180	NULL
min	NULL
after	NULL
the	NULL
stress	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
IxB-	NULL
«	NULL
proteolysis	NULL
and	NULL
p105	NULL
cleavage	NULL
occurred	NULL
concomitantly	NULL
with	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-kB	NULL
,	NULL
demonstrating	NULL
that	NULL
these	NULL
two	NULL
inhibitory	NULL
molecules	NULL
are	NULL
involved	NULL
in	NULL
sequestering	NULL
p50/p65	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
ACH-2	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
cytoplasmic	NULL
p65	NULL
remained	NULL
constant	NULL
after	NULL
HOCl-mediated	NULL
stress	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Hyperthermia	NULL
sensitizes	NULL
ACH-2	NULL
cells	NULL
to	NULL
HOC	NULL
treatment	NULL
Since	NULL
the	NULL
accumulation	NULL
of	NULL
inflammatory	NULL
cells	NULL
in	NULL
a	NULL
damaged	NULL
tissue	NULL
site	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
release	NULL
of	NULL
ROS	NULL
,	NULL
pro-inflammatory	NULL
cytokines	NULL
and	NULL
a	NULL
possible	NULL
rise	NULL
in	NULL
temperature	NULL
[	NULL
37,38	NULL
]	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
role	NULL
of	NULL
hyperthermia	NULL
as	NULL
a	NULL
cofactor	NULL
capable	NULL
of	NULL
enhancing	NULL
the	NULL
efficacy	NULL
of	NULL
HOC	NULL
]	NULL
in	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
first	NULL
subjected	NULL
to	NULL
a	NULL
slow	NULL
increase	NULL
in	NULL
temperature	NULL
,	NULL
from	NULL
37	NULL
to	NULL
42	NULL
°C	NULL
in	NULL
30	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
then	NULL
being	NULL
maintained	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
40	NULL
min	NULL
.	NULL

The	NULL
temperature	NULL
was	NULL
then	NULL
restored	NULL
to	NULL
37	NULL
°C	NULL
within	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
taken	NULL
at	NULL
various	NULL
phases	NULL
of	NULL
temperature	NULL
variation	NULL
and	NULL
were	NULL
analysed	NULL
by	NULL
a	NULL
gel-retardation	NULL
assay	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

No	NULL
retarded	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
could	NULL
be	NULL
detected	NULL
on	NULL
the	NULL
gel	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
this	NULL
factor	NULL
was	NULL
not	NULL
significantly	NULL
activated	NULL
during	NULL
and	NULL
after	NULL
the	NULL
hyperthermia	NULL
.	NULL

In	NULL
a	NULL
second	NULL
step	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
hyperthermic	NULL
stress	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
above	NULL
before	NULL
being	NULL
stressed	NULL
directly	NULL
by	NULL
various	NULL
HOC	NULL
concentrations	NULL
as	NULL
soon	NULL
as	NULL
the	NULL
temperature	NULL
had	NULL
returned	NULL
to	NULL
37	NULL
°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
180	NULL
min	NULL
after	NULL
the	NULL
end	NULL
of	NULL
the	NULL
hyperthermia	NULL
for	NULL
analysis	NULL
by	NULL
a	NULL
gel-retardation	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
retarded	NULL
band	NULL
appeared	NULL
clearly	NULL
at	NULL
low	NULL
HOC	NULL
concentrations	NULL
,	NULL
i.e	NULL
.	NULL

between	NULL
100	NULL
and	NULL
150	NULL
gM	NULL
.	NULL

In	NULL
cells	NULL
not	NULL
exposed	NULL
to	NULL
hyperthermia	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
not	NULL
detectable	NULL
at	NULL
these	NULL
HOC	NULL
]	NULL
concentrations	NULL
.	NULL

At	NULL
higher	NULL
HOC	NULL
]	NULL
concentrations	NULL
(	NULL
200-300	NULL
M	NULL
)	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
was	NULL
clearly	NULL
3-fold	NULL
less	NULL
intense	NULL
in	NULL
non-hyperthermic	NULL
cells	NULL
compared	NULL
with	NULL
cells	NULL
subjected	NULL
to	NULL
one	NULL
round	NULL
of	NULL
hyperthermia	NULL
.	NULL

Antioxidants	NULL
block	NULL
NF-xB	NULL
induction	NULL
by	NULL
HOC	NULL
!	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
HOC	NULL
]	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
ACH-2	NULL
cells	NULL
through	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
involving	NULL
the	NULL
intracellular	NULL
release	NULL
of	NULL
ROS	NULL
,	NULL
because	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
very	NULL
closely	NULL
resemble	NULL
those	NULL
observed	NULL
when	NULL
H	NULL
,	NULL
O	NULL
,	NULL
is	NULL
added	NULL
to	NULL
either	NULL
lymphocyte	NULL
or	NULL
monocyte	NULL
[	NULL
11,39	NULL
]	NULL
.	NULL

We	NULL
thus	NULL
investigated	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
intermediates	NULL
suspected	NULL
of	NULL
mediating	NULL
HOCl-dependent	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
ACH-2	NULL
cells	NULL
.	NULL

The	NULL
free	NULL
radical	NULL
scavenger	NULL
pyrrolidine-dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
and	NULL
nordihydroguaiaretic	NULL
acid	NULL
[	NULL
40	NULL
]	NULL
were	NULL
able	NULL
to	NULL
suppress	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
after	NULL
HOC	NULL
stimulation	NULL
of	NULL
ACH-2	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
the	NULL
inhibition	NULL
being	NULL
almost	NULL
complete	NULL
at	NULL
100	NULL
zM	NULL
PDTC	NULL
.	NULL

Since	NULL
the	NULL
generation	NULL
of	NULL
intracellular	NULL
ROS	NULL
could	NULL
proceed	NULL
through	NULL
the	NULL
involvement	NULL
of	NULL
phospholipase	NULL
A2	NULL
(	NULL
PLA2	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
these	NULL
enzymes	NULL
on	NULL
HOCl-mediated	NULL
NF-KB	NULL
activation	NULL
by	NULL
using	NULL
an	NULL
inhibitor	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
PLA2	NULL
was	NULL
evaluated	NULL
by	NULL
using	NULL
p-bromophenacyl-bromide	NULL
(	NULL
BPB	NULL
)	NULL
,	NULL
an	NULL
irreversible	NULL
inhibitor	NULL
of	NULL
PLA2	NULL
[	NULL
41	NULL
]	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
BPB	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
HOC	NULL
.	NULL

Nontoxic	NULL
concentrations	NULL
of	NULL
BPB	NULL
strongly	NULL
inhibited	NULL
,	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
HOC	NULL
]	NULL
,	NULL
demonstrating	NULL
the	NULL
importance	NULL
of	NULL
PLA2	NULL
in	NULL
the	NULL
pathway	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

TNF-	NULL
is	NULL
released	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
HOCI	NULL
or	NULL
H,0	NULL
,	NULL
In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
in	NULL
the	NULL
cell	NULL
supernatant	NULL
after	NULL
an	NULL
oxidative	NULL
stress	NULL
mediated	NULL
either	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
HOC	NULL
,	NULL
IL-1	NULL
#	NULL
and	NULL
TNF-	NULL
«	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
cell	NULL
supernatants	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-1/	NULL
#	NULL
released	NULL
by	NULL
ACH-2	NULL
cells	NULL
after	NULL
these	NULL
oxidative	NULL
stresses	NULL
was	NULL
very	NULL
low	NULL
and	NULL
was	NULL
only	NULL
very	NULL
weakly	NULL
stimulated	NULL
by	NULL
either	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
HOC	NULL
]	NULL
compared	NULL
with	NULL
the	NULL
background	NULL
levels	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
less	NULL
than	NULL
5	NULL
pg/ml	NULL
TNF-a	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
untreated	NULL
ACH-2	NULL
cells	NULL
during	NULL
the	NULL
first	NULL
8	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

This	NULL
amount	NULL
was	NULL
increased	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
both	NULL
chemicals	NULL
.	NULL

With	NULL
H,0	NULL
,	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
TNF-	NULL
«	NULL
released	NULL
was	NULL
stimulated	NULL
more	NULL
than	NULL
20-fold	NULL
until	NULL
8	NULL
h	NULL
after	NULL
the	NULL
stress	NULL
,	NULL
before	NULL
returning	NULL
to	NULL
the	NULL
level	NULL
observed	NULL
in	NULL
untreated	NULL
ACH-2	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

The	NULL
same	NULL
behaviour	NULL
was	NULL
observed	NULL
with	NULL
HOC	NULL
,	NULL
except	NULL
that	NULL
the	NULL
amplitude	NULL
was	NULL
lower	NULL
,	NULL
with	NULL
maximal	NULL
stimulation	NULL
being	NULL
~	NULL
5-fold	NULL
after	NULL
8	NULL
h.	NULL
Addition	NULL
of	NULL
25	NULL
ug/ml	NULL
CHX	NULL
before	NULL
the	NULL
stress	NULL
mediated	NULL
by	NULL
H,0	NULL
,	NULL
or	NULL
HOC	NULL
abolished	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
the	NULL
supernatant	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
782	NULL
S.	NULL
Schoonbroodt	NULL
and	NULL
others	NULL
Table	NULL
1	NULL
-	NULL
Inhibition	NULL
of	NULL
HOCl-mediated	NULL
NF-xB	NULL
Induction	NULL
by	NULL
antloxidants	NULL
ACH-2	NULL
cells	NULL
treated	NULL
with	NULL
200	NULL
M	NULL
HOC	NULL
for	NULL
180	NULL
min	NULL
were	NULL
either	NULL
preincubated	NULL
or	NULL
not	NULL
with	NULL
various	NULL
inhibitors	NULL
:	NULL
a	NULL
PLAZ	NULL
inhibitor	NULL
,	NULL
BPB	NULL
,	NULL
the	NULL
free	NULL
radicals	NULL
scavenger	NULL
PDTC	NULL
and	NULL
nordihydroguaiaretic	NULL
acid	NULL
(	NULL
NDGA	NULL
)	NULL
.	NULL

Results	NULL
show	NULL
percentages	NULL
of	NULL
NF-B	NULL
inducibility	NULL
in	NULL
comparison	NULL
with	NULL
HOC	NULL
induction	NULL
,	NULL
which	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
100	NULL
%	NULL
.	NULL

Inhibitor	NULL
NF-	NULL
«	NULL
B	NULL
inducibility	NULL
Inhibitor	NULL
(	NULL
gM	NULL
)	NULL
(	NULL
%	NULL
)	NULL
-	NULL
-	NULL
100	NULL
PDTC	NULL
60	NULL
89	NULL
PDTC	NULL
100	NULL
14	NULL
NDGA	NULL
30	NULL
14	NULL
NDGA	NULL
50	NULL
5.3	NULL
BPB	NULL
2	NULL
24.4	NULL
BPB	NULL
5	NULL
0.1	NULL
30	NULL
B	NULL
&	NULL
20	NULL
9	NULL
8	NULL
3	NULL
£2	NULL
$	NULL
5	NULL
10	NULL
m	NULL
0	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
6	NULL
-	NULL
TNF-	NULL
«	NULL
Is	NULL
released	NULL
after	NULL
treating	NULL
ACH-2	NULL
cells	NULL
with	NULL
elther	NULL
H,0	NULL
,	NULL
or	NULL
HOCI	NULL
Time-course	NULL
of	NULL
TNF-	NULL
«	NULL
release	NULL
following	NULL
ACH-2	NULL
cell	NULL
treatment	NULL
with	NULL
200	NULL
aM	NULL
HOCI	NULL
(	NULL
¥	NULL
)	NULL
or	NULL
100	NULL
M	NULL
H	NULL
;	NULL
0	NULL
,	NULL
(	NULL
@	NULL
)	NULL
;	NULL
(	NULL
]	NULL
)	NULL
represents	NULL
the	NULL
time-course	NULL
of	NULL
TNF-a	NULL
release	NULL
in	NULL
untreated	NULL
ACH-2	NULL
cells	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
cell	NULL
supernatants	NULL
were	NULL
directly	NULL
taken	NULL
for	NULL
TNF-x	NULL
quantification	NULL
by	NULL
EASIA	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
sight	NULL
independent	NULL
experiments	NULL
.	NULL

small	NULL
amount	NULL
of	NULL
TNF-	NULL
«	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
ACH-2	NULL
cells	NULL
and	NULL
that	NULL
both	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
HOC	NULL
]	NULL
can	NULL
rapidly	NULL
stimulate	NULL
its	NULL
release	NULL
.	NULL

TNF-	NULL
«	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
NF-xB	NULL
induction	NULL
by	NULL
both	NULL
H,0	NULL
,	NULL
and	NULL
HOGI	NULL
In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
functionality	NULL
of	NULL
the	NULL
TNF-a	NULL
released	NULL
in	NULL
cell	NULL
supernatants	NULL
in	NULL
terms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inducibility	NULL
,	NULL
we	NULL
treated	NULL
ACH-2	NULL
cells	NULL
with	NULL
equivalent	NULL
TNF-	NULL
«	NULL
concentrations	NULL
to	NULL
those	NULL
released	NULL
in	NULL
supernatants	NULL
after	NULL
treatment	NULL
with	NULL
H,0	NULL
,	NULL
or	NULL
HOC	NULL
,	NULL
i.e	NULL
.	NULL

100	NULL
and	NULL
33	NULL
pg/ml	NULL
respectively	NULL
(	NULL
or	NULL
16.6	NULL
and	NULL
5	NULL
units/ml	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
30	NULL
,	NULL
60	NULL
and	NULL
120	NULL
min	NULL
after	NULL
induction	NULL
and	NULL
analysed	NULL
by	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
(	NULL
A	NULL
)	NULL
,	NULL
a	NULL
rather	NULL
important	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
ACH-2	NULL
cells	NULL
treated	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
supernatants	NULL
of	NULL
ACH-2	NULL
cells	NULL
pretreated	NULL
with	NULL
either	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
or	NULL
HOC	NULL
(	NULL
200	NULL
4M	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
transferred	NULL
onto	NULL
untreated	NULL
ACH-2	NULL
cells	NULL
before	NULL
being	NULL
used	NULL
to	NULL
prepare	NULL
nuclear	NULL
extracts	NULL
30	NULL
,	NULL
60	NULL
or	NULL
120	NULL
min	NULL
after	NULL
supernatant	NULL
addition	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
(	NULL
B	NULL
)	NULL
,	NULL
a	NULL
clear	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
can	NULL
be	NULL
induced	NULL
60	NULL
min	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
supernatant	NULL
taken	NULL
from	NULL
ACH-2	NULL
cells	NULL
treated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
180	NULL
min	NULL
.	NULL

Similar	NULL
observations	NULL
can	NULL
be	NULL
made	NULL
with	NULL
supernatants	NULL
TNF-	NULL
(	NULL
U/ml	NULL
!	NULL
)	NULL

wn	NULL
w	NULL
in	NULL
time	NULL
(	NULL
min	NULL
)	NULL
30	NULL
60	NULL
120	NULL
30	NULL
60	NULL
120	NULL
B.	NULL
time	NULL
(	NULL
min	NULL
)	NULL
30	NULL
60	NULL
120	NULL
30	NULL
60	NULL
120	NULL
30	NULL
60	NULL
120	NULL
supernatant	NULL
alone	NULL
$	NULL
o	NULL
#	NULL
o	NULL
$	NULL
o	NULL
>	NULL
%	NULL
%	NULL
=	NULL
e	NULL
=	NULL
+anti-mouse	NULL
IgG	NULL
=	NULL
=	NULL
=	NULL
+o	NULL
#	NULL
+	NULL
#	NULL
=	NULL
=	NULL
=	NULL
+anti-mouse	NULL
|	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
Ps	NULL
$	NULL
#	NULL
0	NULL
%	NULL
I	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
C.	NULL
WT	NULL
-	NULL
Mut	NULL
Competitor	NULL
_	NULL
-	NULL
50x	NULL
50	NULL
%	NULL
2	NULL
3	NULL
Figure	NULL
7	NULL
TNF-	NULL
«	NULL
released	NULL
by	NULL
treating	NULL
cells	NULL
elther	NULL
with	NULL
H,0	NULL
,	NULL
or	NULL
HOCI	NULL
Is	NULL
blologically	NULL
active	NULL
(	NULL
A	NULL
)	NULL
Low	NULL
TNF-a	NULL
concentrations	NULL
can	NULL
induce	NULL
NF-xB	NULL
.	NULL

Medium	NULL
of	NULL
ACH-2	NULL
cells	NULL
was	NULL
supplemented	NULL
with	NULL
5	NULL
and	NULL
16.6	NULL
units/ml	NULL
TNF-	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
30	NULL
,	NULL
60	NULL
and	NULL
120	NULL
min	NULL
after	NULL
the	NULL
treatment	NULL
.	NULL

An	NULL
equal	NULL
amount	NULL
of	NULL
protein	NULL
was	NULL
mixed	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
probe	NULL
encompassing	NULL
the	NULL
«	NULL
B	NULL
elements	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
on	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
electrophoresed	NULL
at	NULL
150	NULL
V.	NULL
The	NULL
autoradiogram	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TNF-	NULL
«	NULL
detected	NULL
in	NULL
H,0	NULL
,	NULL
-	NULL
or	NULL
HOCH-treated	NULL
cell	NULL
supernatant	NULL
has	NULL
conserved	NULL
its	NULL
biological	NULL
properties	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
show	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
time-course	NULL
experiment	NULL
when	NULL
supernatant	NULL
was	NULL
directly	NULL
transferred	NULL
onto	NULL
untreated	NULL
ACH-2	NULL
cells	NULL
.	NULL

In	NULL
columns	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
supernatant	NULL
was	NULL
depleted	NULL
of	NULL
TNF-x	NULL
using	NULL
an	NULL
anti-TNF-	NULL
«	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Boghringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

(	NULL
G	NULL
)	NULL
Competition	NULL
with	NULL
an	NULL
unlabelled	NULL
oligonucleotide	NULL
(	NULL
50	NULL
M	NULL
excess	NULL
)	NULL
encompassing	NULL
NF-KB	NULL
sites	NULL
reveals	NULL
the	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
NF-xB	NULL
complex	NULL
.	NULL

The	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
could	NULL
not	NULL
be	NULL
competed	NULL
out	NULL
with	NULL
a	NULL
50	NULL
M	NULL
excess	NULL
of	NULL
the	NULL
mutated	NULL
NF-xB	NULL
probe	NULL
.	NULL

WT	NULL
,	NULL
wild-type	NULL
probe	NULL
;	NULL
mut	NULL
,	NULL
mutated	NULL
probe	NULL
.	NULL

collected	NULL
from	NULL
ACH-2	NULL
cells	NULL
treated	NULL
for	NULL
180	NULL
min	NULL
with	NULL
HOC	NULL
]	NULL
,	NULL
except	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
somewhat	NULL
less	NULL
intense	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
traces	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
remaining	NULL
in	NULL
cell	NULL
supernatants	NULL
were	NULL
eliminated	NULL
by	NULL
treating	NULL
supernatants	NULL
with	NULL
10	NULL
units/ml	NULL
catalase	NULL
.	NULL

To	NULL
verify	NULL
whether	NULL
the	NULL
effect	NULL
was	NULL
due	NULL
to	NULL
TNF-	NULL
@	NULL
release	NULL
subsequent	NULL
to	NULL
oxidative	NULL
stress	NULL
,	NULL
supernatants	NULL
were	NULL
treated	NULL
with	NULL
Sepharose	NULL
beads	NULL
to	NULL
which	NULL
either	NULL
anti-TNF-	NULL
«	NULL
monoclonal	NULL
antibody	NULL
or	NULL
an	NULL
irrelevant	NULL
antibody	NULL
was	NULL
attached	NULL
.	NULL

The	NULL
supernatants	NULL
thus	NULL
treated	NULL
were	NULL
added	NULL
to	NULL
ACH-2	NULL
cells	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
30	NULL
,	NULL
60	NULL
or	NULL
120	NULL
min	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
(	NULL
B	NULL
)	NULL
,	NULL
the	NULL
treatment	NULL
of	NULL
cell	NULL
supernatants	NULL
taken	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
H,0	NULL
,	NULL
,	NULL
with	NULL
the	NULL
beads	NULL
linked	NULL
to	NULL
an	NULL
anti-TNF-	NULL
«	NULL
antibody	NULL
,	NULL
abolished	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
,	NULL
while	NULL
beads	NULL
alone	NULL
did	NULL
not	NULL
modify	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
supernatant	NULL
transfer	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
shown	NULL
by	NULL
its	NULL
disappearance	NULL
through	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
probe	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
mutated	NULL
probe	NULL
(	NULL
Figure	NULL
7C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
NF-KB	NULL
activation	NULL
by	NULL
hypochlorous	NULL
acid	NULL
1783	NULL
TNF-z	NULL
0	NULL
20	NULL
20	NULL
20	NULL
20	NULL
(	NULL
units/ml	NULL
)	NULL
s	NULL
$	NULL
g	NULL
HOC	NULL
roe	NULL
S	NULL
A	NULL
&	NULL
Specific	NULL
___	NULL
.	NULL

ta	NULL
tJ	NULL
complex	NULL
tual	NULL
«	NULL
=	NULL
tous	NULL
toa	NULL
Free	NULL
_.	NULL
probe	NULL
Figure	NULL
8	NULL
-	NULL
HOCGI	NULL
and	NULL
TNF-	NULL
«	NULL
can	NULL
cooperate	NULL
to	NULL
Induce	NULL
NF-xB	NULL
Induction	NULL
of	NULL
a	NULL
nuclear	NULL
NF-KB	NULL
by	NULL
treatment	NULL
of	NULL
ACH-2	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
HOCI	NULL
(	NULL
100-300	NULL
M	NULL
)	NULL
after	NULL
a	NULL
pretreatment	NULL
with	NULL
20	NULL
units/ml	NULL
TNF-	NULL
«	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
180	NULL
min	NULL
after	NULL
treatment	NULL
with	NULL
HOCI	NULL
,	NULL
and	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
protein	NULL
was	NULL
mixed	NULL
with	NULL
a	NULL
**P-labelled	NULL
NF-B	NULL
probe	NULL
.	NULL

Samples	NULL
were	NULL
analysed	NULL
as	NULL
in	NULL
Figure	NULL
1.	NULL
that	NULL
TNF-a	NULL
released	NULL
after	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
HOC	NULL
]	NULL
is	NULL
functional	NULL
and	NULL
is	NULL
an	NULL
important	NULL
secondary	NULL
messenger	NULL
which	NULL
could	NULL
be	NULL
propagated	NULL
to	NULL
uninduced	NULL
cells	NULL
.	NULL

Pretreatment	NULL
with	NULL
TNF-a	NULL
sensitizes	NULL
ACH-2	NULL
cells	NULL
to	NULL
HOC	NULL
To	NULL
corroborate	NULL
the	NULL
demonstration	NULL
that	NULL
TNF-a	NULL
played	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
HOCH	NULL
,	NULL
ACH-2	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
TNF-a	NULL
before	NULL
being	NULL
stressed	NULL
with	NULL
HOC	NULL
in	NULL
order	NULL
to	NULL
reveal	NULL
potential	NULL
additive	NULL
or	NULL
synergistic	NULL
effects	NULL
between	NULL
these	NULL
two	NULL
agents	NULL
.	NULL

ACH-2	NULL
cells	NULL
were	NULL
first	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
0	NULL
,	NULL
20	NULL
or	NULL
200	NULL
units/ml	NULL
)	NULL
for	NULL
90	NULL
min	NULL
.	NULL

After	NULL
induction	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analysed	NULL
by	NULL
gel-retardation	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
8	NULL
,	NULL
a	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
could	NULL
be	NULL
clearly	NULL
seen	NULL
,	NULL
even	NULL
at	NULL
TNF-concentrations	NULL
as	NULL
low	NULL
as	NULL
20	NULL
units/ml	NULL
;	NULL
this	NULL
stimulation	NULL
was	NULL
slightly	NULL
increased	NULL
for	NULL
higher	NULL
TNF-	NULL
«	NULL
concentrations	NULL
.	NULL

When	NULL
these	NULL
cells	NULL
were	NULL
prestimulated	NULL
with	NULL
TNF-a	NULL
at	NULL
either	NULL
20	NULL
or	NULL
200	NULL
units/ml	NULL
and	NULL
stressed	NULL
90	NULL
min	NULL
later	NULL
with	NULL
HOC	NULL
]	NULL
ranging	NULL
from	NULL
100	NULL
to	NULL
300	NULL
zM	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
significantly	NULL
higher	NULL
than	NULL
in	NULL
non-pretreated	NULL
cells	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
again	NULL
demonstrate	NULL
that	NULL
cell	NULL
pretreatment	NULL
with	NULL
TNF-	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
generate	NULL
intracellular	NULL
ROS	NULL
,	NULL
renders	NULL
ACH-2	NULL
cells	NULL
more	NULL
sensitive	NULL
to	NULL
subsequent	NULL
stress	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
,	NULL
in	NULL
terms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
induction	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
work	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
exposure	NULL
of	NULL
a	NULL
T-lymphocyte	NULL
cell	NULL
line	NULL
to	NULL
an	NULL
oxidizing	NULL
treatment	NULL
mediated	NULL
by	NULL
HOC	NULL
]	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

The	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induced	NULL
by	NULL
HOC	NULL
]	NULL
is	NULL
the	NULL
heterodimer	NULL
p50/p65	NULL
.	NULL

This	NULL
induction	NULL
presents	NULL
the	NULL
same	NULL
characteristics	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
PMA	NULL
,	NULL
lectins	NULL
or	NULL
cytokines	NULL
[	NULL
19,20	NULL
]	NULL
,	NULL
except	NULL
that	NULL
induction	NULL
was	NULL
slower	NULL
in	NULL
the	NULL
case	NULL
of	NULL
HOC	NULL
.	NULL

This	NULL
may	NULL
occur	NULL
,	NULL
either	NULL
because	NULL
HOC	NULL
]	NULL
alters	NULL
one	NULL
of	NULL
the	NULL
components	NULL
(	NULL
e.g	NULL
.	NULL

a	NULL
cytoplasmic	NULL
signalling	NULL
protein	NULL
)	NULL
involved	NULL
in	NULL
activation	NULL
,	NULL
or	NULL
because	NULL
HOC	NULL
]	NULL
is	NULL
not	NULL
produced	NULL
close	NULL
enough	NULL
to	NULL
(	NULL
i.e	NULL
.	NULL

does	NULL
not	NULL
directly	NULL
damage	NULL
)	NULL
the	NULL
cellular	NULL
component	NULL
from	NULL
which	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
initiated	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
by	NULL
HOC	NULL
seems	NULL
to	NULL
be	NULL
completely	NULL
achieved	NULL
after	NULL
4	NULL
h	NULL
,	NULL
possibly	NULL
because	NULL
several	NULL
different	NULL
activation	NULL
pathways	NULL
could	NULL
well	NULL
be	NULL
required	NULL
for	NULL
full	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
perhaps	NULL
likely	NULL
that	NULL
an	NULL
identical	NULL
sensor	NULL
molecule	NULL
is	NULL
activated	NULL
by	NULL
both	NULL
H,0	NULL
,	NULL
and	NULL
HOCH	NULL
]	NULL
,	NULL
triggering	NULL
IkB-a	NULL
and	NULL
p105	NULL
degradation	NULL
and	NULL
allowing	NULL
p50/p65	NULL
to	NULL
migrate	NULL
inside	NULL
the	NULL
cell	NULL
nucleus	NULL
to	NULL
activate	NULL
genes	NULL
harboring	NULL
NF-	NULL
«	NULL
B	NULL
responsive	NULL
elements	NULL
in	NULL
their	NULL
promoters	NULL
[	NULL
1,4	NULL
]	NULL
.	NULL

The	NULL
candidate	NULL
sensory	NULL
molecule	NULL
would	NULL
be	NULL
oxidized	NULL
by	NULL
both	NULL
HOC	NULL
]	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
would	NULL
transmit	NULL
the	NULL
message	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
inhibitory	NULL
subunits	NULL
,	NULL
retaining	NULL
inactive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

The	NULL
cellular	NULL
damage	NULL
generated	NULL
by	NULL
HOC	NULL
]	NULL
is	NULL
as	NULL
diversified	NULL
as	NULL
that	NULL
caused	NULL
by	NULL
exposure	NULL
to	NULL
H,0	NULL
,	NULL
,	NULL
if	NULL
it	NULL
is	NULL
assumed	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
acts	NULL
through	NULL
generation	NULL
of	NULL
hydroxyl	NULL
radicals	NULL
in	NULL
Fenton	NULL
reactions	NULL
.	NULL

With	NULL
a	NULL
pK	NULL
,	NULL
of	NULL
7.53	NULL
,	NULL
HOC	NULL
exists	NULL
in	NULL
essentially	NULL
equal	NULL
concentrations	NULL
as	NULL
the	NULL
conjugate	NULL
base	NULL
hypochlorite	NULL
(	NULL
OCT	NULL
)	NULL
[	NULL
30,42	NULL
]	NULL
.	NULL

HOCI/OCI-	NULL
is	NULL
a	NULL
powerful	NULL
biologically	NULL
relevant	NULL
oxidizing	NULL
agent	NULL
and	NULL
can	NULL
introduce	NULL
damage	NULL
to	NULL
protein	NULL
,	NULL
lipid	NULL
,	NULL
carbohydrate	NULL
and	NULL
nucleic	NULL
acid	NULL
[	NULL
43-45	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
reaction	NULL
of	NULL
HOC	NULL
with	NULL
amino	NULL
and	NULL
imino	NULL
acids	NULL
is	NULL
known	NULL
to	NULL
generate	NULL
long-lived	NULL
N-chloroamines	NULL
[	NULL
27,46	NULL
]	NULL
.	NULL

Although	NULL
N-chloroamines	NULL
exhibit	NULL
a	NULL
lower	NULL
oxidizing	NULL
potential	NULL
than	NULL
HOC	NULL
,	NULL
their	NULL
much	NULL
longer	NULL
lifetimes	NULL
may	NULL
enable	NULL
such	NULL
species	NULL
to	NULL
cause	NULL
damage	NULL
at	NULL
distant	NULL
sites	NULL
[	NULL
27,47	NULL
]	NULL
.	NULL

In	NULL
constrast	NULL
,	NULL
HOC	NULL
]	NULL
is	NULL
thought	NULL
to	NULL
react	NULL
close	NULL
to	NULL
its	NULL
site	NULL
of	NULL
production	NULL
[	NULL
44,45	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
addition	NULL
of	NULL
HOC	NULL
]	NULL
directly	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
would	NULL
damage	NULL
T-lymphocyte	NULL
membranes	NULL
,	NULL
modifying	NULL
proteins	NULL
and	NULL
generating	NULL
lipid	NULL
peroxidation	NULL
.	NULL

These	NULL
two	NULL
kinds	NULL
of	NULL
oxidation	NULL
products	NULL
,	NULL
i.e	NULL
.	NULL

protein	NULL
modifications	NULL
and	NULL
lipid	NULL
peroxidation	NULL
products	NULL
,	NULL
have	NULL
been	NULL
recognized	NULL
as	NULL
being	NULL
stimuli	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
see	NULL
[	NULL
4,48	NULL
]	NULL
for	NULL
reviews	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T-cells	NULL
with	NULL
millimolar	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
generates	NULL
the	NULL
association	NULL
between	NULL
the	NULL
£	NULL
and	NULL
e	NULL
chains	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
with	NULL
ZAP-70	NULL
kinase	NULL
[	NULL
21,22	NULL
]	NULL
.	NULL

This	NULL
event	NULL
occurs	NULL
very	NULL
rapidly	NULL
after	NULL
treatment	NULL
,	NULL
and	NULL
is	NULL
suspected	NULL
to	NULL
be	NULL
crucial	NULL
in	NULL
the	NULL
transduction	NULL
pathways	NULL
initiated	NULL
by	NULL
H,0	NULL
,	NULL
.	NULL

Because	NULL
HOC	NULL
is	NULL
known	NULL
to	NULL
generate	NULL
chlorinated	NULL
adducts	NULL
on	NULL
proteins	NULL
[	NULL
44,48	NULL
]	NULL
,	NULL
it	NULL
can	NULL
be	NULL
envisaged	NULL
that	NULL
these	NULL
oxidation	NULL
products	NULL
could	NULL
favour	NULL
the	NULL
formation	NULL
of	NULL
protein-protein	NULL
interactions	NULL
such	NULL
as	NULL
those	NULL
between	NULL
tyrosine	NULL
kinases	NULL
and	NULL
membrane	NULL
receptors	NULL
.	NULL

These	NULL
events	NULL
would	NULL
take	NULL
place	NULL
at	NULL
the	NULL
cellular	NULL
membrane	NULL
and	NULL
would	NULL
be	NULL
initiated	NULL
by	NULL
oxidative	NULL
damage	NULL
generated	NULL
by	NULL
HOC	NULL
]	NULL
.	NULL

HOC	NULL
]	NULL
is	NULL
also	NULL
known	NULL
to	NULL
generate	NULL
DNA-oxidation	NULL
products	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
several	NULL
authors	NULL
that	NULL
DNA	NULL
damage	NULL
[	NULL
35,49,50	NULL
]	NULL
,	NULL
especially	NULL
thymidine	NULL
dimers	NULL
induced	NULL
by	NULL
UV	NULL
light	NULL
,	NULL
could	NULL
also	NULL
be	NULL
an	NULL
event	NULL
triggering	NULL
a	NULL
transduction	NULL
pathway	NULL
leading	NULL
to	NULL
IxB-	NULL
«	NULL
phosphorylation	NULL
[	NULL
49,50	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
summary	NULL
,	NULL
it	NULL
can	NULL
be	NULL
proposed	NULL
that	NULL
HOC	NULL
]	NULL
is	NULL
an	NULL
oxidant	NULL
that	NULL
behaves	NULL
somewhat	NULL
like	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
various	NULL
transduction	NULL
pathways	NULL
initiated	NULL
at	NULL
several	NULL
cellular	NULL
localizations	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
events	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
HOC	NULL
]	NULL
,	NULL
we	NULL
have	NULL
used	NULL
inhibitors	NULL
known	NULL
to	NULL
act	NULL
in	NULL
a	NULL
signal-transduction	NULL
pathway	NULL
yielding	NULL
ROS	NULL
[	NULL
51	NULL
]	NULL
.	NULL

Inhibition	NULL
of	NULL
PLA2	NULL
was	NULL
shown	NULL
to	NULL
prevent	NULL
NF-kB	NULL
activation	NULL
by	NULL
HOCI	NULL
.	NULL

We	NULL
further	NULL
observed	NULL
that	NULL
HOCl-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
completely	NULL
abolished	NULL
by	NULL
antioxidants	NULL
such	NULL
as	NULL
PDTC	NULL
or	NULL
nordihydroguaiaretic	NULL
acid	NULL
,	NULL
which	NULL
concurs	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
intracellular	NULL
ROS	NULL
generation	NULL
may	NULL
be	NULL
the	NULL
ultimate	NULL
step	NULL
leading	NULL
to	NULL
784	NULL
S.	NULL
Schoonbroodt	NULL
and	NULL
others	NULL
IkB-a	NULL
or	NULL
p105	NULL
phoshorylation	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
needed	NULL
to	NULL
fully	NULL
characterize	NULL
all	NULL
the	NULL
intermediates	NULL
involved	NULL
in	NULL
this	NULL
pathway	NULL
,	NULL
especially	NULL
the	NULL
redox-regulated	NULL
kinase	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
intracellular	NULL
ROS	NULL
and	NULL
suspected	NULL
of	NULL
being	NULL
involved	NULL
in	NULL
IkB-a	NULL
or	NULL
p105	NULL
phosphorylation	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
inhibitors	NULL
other	NULL
than	NULL
antioxidants	NULL
can	NULL
prevent	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
HOC	NULL
suggests	NULL
that	NULL
intracellular	NULL
ROS	NULL
are	NULL
generated	NULL
subsequent	NULL
to	NULL
the	NULL
initial	NULL
reaction	NULL
mediated	NULL
by	NULL
HOCI	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
response	NULL
to	NULL
other	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
,	NULL
lipopolysaccharide	NULL
,	NULL
or	NULL
anti-CD	NULL
28	NULL
,	NULL
can	NULL
be	NULL
abolished	NULL
by	NULL
antioxidants	NULL
,	NULL
suggesting	NULL
that	NULL
ROS	NULL
may	NULL
represent	NULL
widely	NULL
used	NULL
secondary	NULL
messenger	NULL
molecules	NULL
in	NULL
lymphocytes	NULL
or	NULL
monocytes	NULL
[	NULL
1,51-54	NULL
]	NULL
.	NULL

Within	NULL
the	NULL
spectrum	NULL
of	NULL
systemic	NULL
reactions	NULL
to	NULL
inflammation	NULL
,	NULL
several	NULL
physiological	NULL
responses	NULL
are	NULL
regarded	NULL
as	NULL
being	NULL
associated	NULL
with	NULL
acute	NULL
inflammation	NULL
.	NULL

One	NULL
of	NULL
these	NULL
is	NULL
the	NULL
alteration	NULL
of	NULL
the	NULL
temperature	NULL
set	NULL
point	NULL
in	NULL
the	NULL
hypothalamus	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
febrile	NULL
response	NULL
[	NULL
37,55	NULL
]	NULL
.	NULL

Three	NULL
cytokines	NULL
that	NULL
are	NULL
released	NULL
from	NULL
the	NULL
site	NULL
of	NULL
injury	NULL
(	NULL
IL-1	NULL
,	NULL
TNF	NULL
and	NULL
IL-6	NULL
)	NULL
are	NULL
considered	NULL
to	NULL
regulate	NULL
the	NULL
febrile	NULL
response	NULL
,	NULL
possibly	NULL
as	NULL
a	NULL
protective	NULL
mechanism	NULL
,	NULL
and	NULL
to	NULL
mediate	NULL
fever	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
prostaglandin	NULL
E2	NULL
[	NULL
37	NULL
]	NULL
.	NULL

Since	NULL
fever	NULL
and	NULL
oxidants	NULL
released	NULL
by	NULL
inflammatory	NULL
cells	NULL
may	NULL
exert	NULL
synergistic	NULL
actions	NULL
in	NULL
modifying	NULL
cellular	NULL
metabolism	NULL
,	NULL
and	NULL
more	NULL
specifically	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
these	NULL
effects	NULL
on	NULL
NF-KB	NULL
induction	NULL
.	NULL

When	NULL
T-cells	NULL
undergo	NULL
one	NULL
round	NULL
of	NULL
hyperthermia	NULL
no	NULL
clear	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
seems	NULL
to	NULL
occur	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
heat-stressed	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
subsequent	NULL
stress	NULL
with	NULL
HOC	NULL
]	NULL
a	NULL
more	NULL
important	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
clear	NULL
evidence	NULL
of	NULL
increased	NULL
susceptibility	NULL
to	NULL
HOCI	NULL
,	NULL
suggesting	NULL
that	NULL
hyperthermia	NULL
can	NULL
constitute	NULL
a	NULL
phase	NULL
which	NULL
can	NULL
significantly	NULL
worsen	NULL
the	NULL
damage	NULL
induced	NULL
by	NULL
a	NULL
second	NULL
oxidative	NULL
stress	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
synergistic	NULL
effects	NULL
between	NULL
fever	NULL
and	NULL
inflammatory	NULL
processes	NULL
might	NULL
occur	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
synergism	NULL
between	NULL
TNF-	NULL
«	NULL
and	NULL
HOC	NULL
]	NULL
has	NULL
been	NULL
also	NULL
demonstrated	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

Because	NULL
TNF-a	NULL
is	NULL
known	NULL
to	NULL
cause	NULL
the	NULL
intracellular	NULL
release	NULL
of	NULL
ROS	NULL
[	NULL
56	NULL
]	NULL
,	NULL
it	NULL
seems	NULL
very	NULL
likely	NULL
that	NULL
cellular	NULL
antioxidant	NULL
defences	NULL
are	NULL
transiently	NULL
depressed	NULL
by	NULL
TNF-a	NULL
treatment	NULL
,	NULL
rendering	NULL
these	NULL
cells	NULL
more	NULL
susceptible	NULL
to	NULL
a	NULL
subsequent	NULL
stress	NULL
,	NULL
mediated	NULL
in	NULL
this	NULL
case	NULL
by	NULL
HOC	NULL
.	NULL

Mitochondria	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
causing	NULL
TNF-induced	NULL
cytotoxicity	NULL
in	NULL
TNF-sensitive	NULL
cells	NULL
[	NULL
56,57	NULL
]	NULL
.	NULL

Presumably	NULL
,	NULL
upon	NULL
TNF-	NULL
«	NULL
stimulation	NULL
,	NULL
mitochondrial	NULL
radicals	NULL
are	NULL
formed	NULL
at	NULL
the	NULL
ubiquinone	NULL
site	NULL
of	NULL
the	NULL
respiratory	NULL
chain	NULL
,	NULL
where	NULL
electrons	NULL
are	NULL
directly	NULL
transferred	NULL
from	NULL
ubisemiquinone	NULL
to	NULL
molecular	NULL
oxygen	NULL
.	NULL

This	NULL
one-electron	NULL
transfer	NULL
results	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
O	NULL
,	NULL
as	NULL
the	NULL
primary	NULL
reactive	NULL
oxygen	NULL
species	NULL
of	NULL
mitochondria	NULL
,	NULL
and	NULL
is	NULL
probably	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
observed	NULL
synergistic	NULL
effect	NULL
between	NULL
hyperthermia	NULL
or	NULL
TNF-	NULL
«	NULL
and	NULL
HOCH	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
another	NULL
important	NULL
aspect	NULL
of	NULL
this	NULL
work	NULL
has	NULL
been	NULL
to	NULL
demonstrate	NULL
that	NULL
oxidative	NULL
stress	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
or	NULL
HOC	NULL
]	NULL
contributes	NULL
significantly	NULL
to	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
in	NULL
cell	NULL
supernatants	NULL
during	NULL
the	NULL
first	NULL
8	NULL
h	NULL
following	NULL
stress	NULL
.	NULL

TNF-	NULL
«	NULL
@	NULL
release	NULL
in	NULL
response	NULL
to	NULL
oxidative	NULL
stress	NULL
is	NULL
a	NULL
very	NULL
important	NULL
observation	NULL
,	NULL
because	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
molecule	NULL
is	NULL
biologically	NULL
active	NULL
and	NULL
capable	NULL
of	NULL
activating	NULL
,	NULL
even	NULL
at	NULL
low	NULL
doses	NULL
,	NULL
non-induced	NULL
cells	NULL
in	NULL
terms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

The	NULL
release	NULL
of	NULL
this	NULL
pro-inflammatory	NULL
cytokine	NULL
should	NULL
contribute	NULL
significantly	NULL
to	NULL
amplification	NULL
and	NULL
also	NULL
propagation	NULL
of	NULL
the	NULL
activation	NULL
message	NULL
to	NULL
non-induced	NULL
cells	NULL
,	NULL
triggering	NULL
a	NULL
generalized	NULL
pro-oxidant	NULL
state	NULL
in	NULL
distant	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
HOC	NULL
]	NULL
,	NULL
which	NULL
is	NULL
produced	NULL
by	NULL
activated	NULL
neutrophils	NULL
,	NULL
can	NULL
contribute	NULL
significantly	NULL
to	NULL
the	NULL
establishment	NULL
of	NULL
pro-oxidant	NULL
conditions	NULL
in	NULL
a	NULL
T-lymphocytic	NULL
cell	NULL
line	NULL
,	NULL
either	NULL
directly	NULL
,	NULL
by	NULL
triggering	NULL
a	NULL
transduction	NULL
pathway	NULL
which	NULL
in	NULL
turn	NULL
leads	NULL
to	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
or	NULL
indirectly	NULL
,	NULL
by	NULL
contributing	NULL
to	NULL
the	NULL
processing	NULL
and	NULL
release	NULL
of	NULL
TNF-	NULL
in	NULL
cell	NULL
supernatants	NULL
.	NULL

Given	NULL
that	NULL
HOC	NULL
has	NULL
a	NULL
rather	NULL
short	NULL
diffusion	NULL
radius	NULL
in	NULL
biological	NULL
media	NULL
because	NULL
of	NULL
its	NULL
rather	NULL
important	NULL
reactivity	NULL
[	NULL
58	NULL
]	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
TNF-a	NULL
can	NULL
be	NULL
released	NULL
in	NULL
response	NULL
to	NULL
its	NULL
reaction	NULL
with	NULL
T-cells	NULL
makes	NULL
it	NULL
possible	NULL
to	NULL
understand	NULL
how	NULL
local	NULL
oxidation	NULL
can	NULL
have	NULL
long-distance	NULL
effects	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Belgian	NULL
National	NULL
Fund	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
NFSR	NULL
,	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
the	NULL
Télévie	NULL
Research	NULL
Program	NULL
funded	NULL
by	NULL
the	NULL
Belgian	NULL
NFSR	NULL
,	NULL
the	NULL
Sidaction	NULL
Research	NULL
Program	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
the	NULL
Concerted	NULL
Action	NULL
Program	NULL
(	NULL
Communauté	NULL
Frangaise	NULL
de	NULL
Belgique	NULL
)	NULL
.	NULL

J.P.	NULL
is	NULL
a	NULL
Research	NULL
Director	NULL
at	NULL
the	NULL
Belgian	NULL
NFSR	NULL
.	NULL

S.S.	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
concerted	NULL
action	NULL
program	NULL
from	NULL
the	NULL
'Communauté	NULL
Frangaise	NULL
de	NULL
Belgique	NULL
'	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
V.	NULL
Bours	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
the	NULL
oligonucleotides	NULL
and	NULL
antibodies	NULL
used	NULL
in	NULL
this	NULL
work	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
the	NULL
NIH	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
(	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
diseases	NULL
,	NULL
NIAID	NULL
,	NULL
Bethesda	NULL
,	NULL
U.S.A.	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
ACH-2	NULL
cell	NULL
line	NULL
.	NULL

REFERENCES	NULL
.	NULL

1	NULL
-	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
2	NULL
-	NULL
Remacle	NULL
,	NULL
J.	NULL
,	NULL
Rags	NULL
,	NULL
M.	NULL
,	NULL
Toussaint	NULL
,	NULL
O.	NULL
,	NULL
Renard	NULL
,	NULL
P.	NULL
and	NULL
Rao	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Mutation	NULL
Res	NULL
.	NULL

316	NULL
,	NULL
103-122	NULL
3	NULL
-	NULL
Schreck	NULL
,	NULL
R.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
39-42	NULL
4	NULL
-	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Albermann	NULL
,	NULL
K.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Free	NULL
Radical	NULL
Res	NULL
.	NULL

Commun	NULL
.	NULL

17	NULL
,	NULL
221-237	NULL
5	NULL
-	NULL
Bose	NULL
,	NULL
Jr.	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1114	NULL
,	NULL
1-17	NULL
6	NULL
-	NULL
Brownell	NULL
,	NULL
E.	NULL
,	NULL
Mittereder	NULL
,	NULL
N.	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
935-942	NULL
7	NULL
-	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
and	NULL
Siebelnist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
685-695	NULL
8	NULL
-	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
and	NULL
Sigbelnist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
348	NULL
,	NULL
76-80	NULL
9	NULL
-	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
2	NULL
,	NULL
1018-1028	NULL
10	NULL
-	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerkove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kouriisky	NULL
,	NULL
P.	NULL
,	NULL
Baguerle	NULL
,	NULL
P.	NULL
A.	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
11	NULL
-	NULL
Baguerle	NULL
,	NULL
P.	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
in	NULL
The	NULL
Hormonal	NULL
Control	NULL
Regulation	NULL
of	NULL
Gene	NULL
Transcription	NULL
,	NULL
(	NULL
Cohen	NULL
,	NULL
P.	NULL
and	NULL
Foulkes	NULL
,	NULL
J.	NULL
,	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
pp	NULL
.	NULL

423-446	NULL
,	NULL
Elsevier	NULL
Science	NULL
Publishers	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
12	NULL
-	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
and	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
13	NULL
-	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

11	NULL
,	NULL
523-537	NULL
14	NULL
-	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlisberger	NULL
,	NULL
U.	NULL
,	NULL
Lahm	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Schlaeger	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
88	NULL
,	NULL
966-970	NULL
15	NULL
-	NULL
Neri	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Lombardi	NULL
,	NULL
M.	NULL
,	NULL
Salina	NULL
,	NULL
M.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Maiolo	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
and	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
1075-1087	NULL
16	NULL
-	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
705-718	NULL
17	NULL
-	NULL
Rice	NULL
,	NULL
N.	NULL
,	NULL
McKichan	NULL
,	NULL
M.	NULL
L.	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
243-253	NULL
18	NULL
-	NULL
Legrand-Poels	NULL
,	NULL
S.	NULL
,	NULL
Vaira	NULL
,	NULL
D.	NULL
,	NULL
Pincemail	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
de	NULL
Vorst	NULL
,	NULL
A.	NULL
and	NULL
Piste	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
6	NULL
,	NULL
1389-1397	NULL
19	NULL
-	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
1.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Nerigh	NULL
,	NULL
Y.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
182-185	NULL
20	NULL
-	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
and	NULL
Sigbenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
90	NULL
,	NULL
2532-2536	NULL
21	NULL
-	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Mittier	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Nadler	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Kanner	NULL
,	NULL
S.	NULL
B.	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

289	NULL
,	NULL
20718-20726	NULL
22	NULL
-	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
649-662	NULL
23	NULL
-	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Myers	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
and	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1212-1220	NULL
24	NULL
-	NULL
Segal	NULL
,	NULL
A.	NULL
W.	NULL
and	NULL
Abo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

18	NULL
,	NULL
43-47	NULL
25	NULL
Weiss	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
New	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

320	NULL
,	NULL
365-376	NULL
26	NULL
-	NULL
Mayeno	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Roberts	NULL
,	NULL
R.	NULL
L.	NULL
and	NULL
Foote	NULL
,	NULL
C.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
5660-5668	NULL
27	NULL
-	NULL
Weiss	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Lampert	NULL
,	NULL
M.	NULL
B.	NULL
and	NULL
Test	NULL
,	NULL
S.	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
222	NULL
,	NULL
625-628	NULL
28	NULL
-	NULL
Grisham	NULL
,	NULL
M.	NULL
B.	NULL
and	NULL
Granger	NULL
,	NULL
D.	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Dig	NULL
.	NULL

Dis	NULL
.	NULL

Sci	NULL
.	NULL

33	NULL
,	NULL
6S-15S	NULL
(	NULL
suppl	NULL
.	NULL
)	NULL

29	NULL
-	NULL
Burdon	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Free	NULL
Radicals	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

18	NULL
,	NULL
775-794	NULL
30	NULL
-	NULL
Morris	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1966	NULL
)	NULL
J.	NULL
Phys	NULL
.	NULL

Chem	NULL
.	NULL

70	NULL
,	NULL
3798-3805	NULL
31	NULL
-	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
and	NULL
Faller	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
2499	NULL
32	NULL
-	NULL
Ryseck	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
Bull	NULL
,	NULL
P.	NULL
,	NULL
Takamiya	NULL
,	NULL
M.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Sigbenlist	NULL
,	NULL
U.	NULL
,	NULL
Dobrzansky	NULL
,	NULL
P.	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
674-684	NULL
33	NULL
-	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Minnel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Drége	NULL
,	NULL
W.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
34	NULL
-	NULL
Piret	NULL
,	NULL
B.	NULL
,	NULL
Legrand-Posls	NULL
,	NULL
S.	NULL
,	NULL
Sappey	NULL
,	NULL
C.	NULL
and	NULL
Piste	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Eur	NULL
J	NULL
Biochem	NULL
.	NULL

228	NULL
,	NULL
441-455	NULL
35	NULL
-	NULL
Legrand-Poels	NULL
,	NULL
S.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Piret	NULL
,	NULL
B.	NULL
,	NULL
Pflaum	NULL
,	NULL
M.	NULL
,	NULL
Epe	NULL
,	NULL
B.	NULL
,	NULL
Rentier	NULL
,	NULL
B.	NULL
and	NULL
Pictte	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
6925-6934	NULL
NF-KB	NULL
activation	NULL
by	NULL
hypochlorous	NULL
acid	NULL
785	NULL
42	NULL
43	NULL
44	NULL
45	NULL
46	NULL
47	NULL
48	NULL
Basuerle	NULL
,	NULL
P.	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
Baumann	NULL
,	NULL
H.	NULL
and	NULL
Gauldie	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
74-80	NULL
Fey	NULL
,	NULL
G.	NULL
H.	NULL
and	NULL
Fuller	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

4	NULL
,	NULL
323-329	NULL
Sappey	NULL
,	NULL
C.	NULL
,	NULL
Legrand-Poels	NULL
,	NULL
S.	NULL
,	NULL
Best-Belpomme	NULL
,	NULL
M.	NULL
,	NULL
Favier	NULL
,	NULL
A.	NULL
,	NULL
Rentier	NULL
,	NULL
A.	NULL
and	NULL
Piette	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
10	NULL
,	NULL
1451-1460	NULL
Rillema	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Leukotrienes	NULL
Med	NULL
.	NULL

16	NULL
,	NULL
89-94	NULL
Lister	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Glaser	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
and	NULL
Dennis	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
8520-8528	NULL
Gordon	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1972	NULL
)	NULL
The	NULL
Chemist	NULL
's	NULL
Companion	NULL
:	NULL
A	NULL
Handbook	NULL
of	NULL
Practical	NULL
Data	NULL
,	NULL
Techniques	NULL
and	NULL
References	NULL
,	NULL
John	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
Test	NULL
,	NULL
S.	NULL
T.	NULL
and	NULL
Weiss	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Adv	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

2	NULL
,	NULL
91-116	NULL
Albricht	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Mc	NULL
Carthy	NULL
,	NULL
C.	NULL
A.	NULL
and	NULL
Hurst	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
78	NULL
,	NULL
210-214	NULL
Harrison	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Watson	NULL
,	NULL
B.	NULL
S.	NULL
and	NULL
Schultz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

92	NULL
,	NULL
327-332	NULL
Weiss	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Klein	NULL
,	NULL
R.	NULL
,	NULL
Slivka	NULL
,	NULL
A.	NULL
and	NULL
Wel	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

70	NULL
,	NULL
598-607	NULL
Siebelnist	NULL
,	NULL
U.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
and	NULL
Brown	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
405-455	NULL
Kiebanoff	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
Inflammation	NULL
:	NULL
Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Correlates	NULL
(	NULL
Gallin	NULL
,	NULL
J.	NULL
I.	NULL
and	NULL
Snyderman	NULL
,	NULL
R.	NULL
,	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
Received	NULL
20	NULL
June	NULL
1996/12	NULL
September	NULL
1996	NULL
;	NULL
accepted	NULL
24	NULL
September	NULL
1996	NULL
49	NULL
50	NULL
51	NULL
52	NULL
53	NULL
54	NULL
56	NULL
57	NULL
58	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Litfin	NULL
,	NULL
M.	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5169-5181	NULL
Yarosh	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Alas	NULL
,	NULL
L.	NULL
,	NULL
Kibitel	NULL
,	NULL
J.	NULL
,	NULL
O'Connor	NULL
,	NULL
A.	NULL
,	NULL
Carrier	NULL
,	NULL
F.	NULL
and	NULL
Fornace	NULL
,	NULL
Jr.	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

100	NULL
,	NULL
790-799	NULL
Los	NULL
,	NULL
M.	NULL
,	NULL
Schenk	NULL
,	NULL
H.	NULL
,	NULL
Hexel	NULL
,	NULL
K.	NULL
,	NULL
Baguerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Drdge	NULL
,	NULL
W.	NULL
and	NULL
Schulze-Ostoff	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
3731-3740	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Raju	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ela	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
87	NULL
,	NULL
4884-4888	NULL
Meyer	NULL
,	NULL
M.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
and	NULL
Basuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2005-2015	NULL
Schenk	NULL
,	NULL
H.	NULL
,	NULL
Klein	NULL
,	NULL
M.	NULL
,	NULL
Erdbriigger	NULL
,	NULL
W.	NULL
,	NULL
Drige	NULL
,	NULL
W.	NULL
and	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
91	NULL
,	NULL
1672-1676	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Cannon	NULL
,	NULL
J.	NULL
G.	NULL
and	NULL
Wolf	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Rev	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

10	NULL
,	NULL
34-64	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Bakker	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Vanhaesebroeck	NULL
,	NULL
B.	NULL
,	NULL
Bayert	NULL
,	NULL
R.	NULL
,	NULL
Jacobs	NULL
,	NULL
W.	NULL
and	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
5317-5323	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Bayert	NULL
,	NULL
R.	NULL
,	NULL
Vandevoorde	NULL
,	NULL
V.	NULL
,	NULL
Haegeman	NULL
,	NULL
G.	NULL
and	NULL
Fliers	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3095-3104	NULL
Folkes	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Candeias	NULL
,	NULL
L.	NULL
P.	NULL
and	NULL
Wardman	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

323	NULL
,	NULL
120-126	NULL

